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Capsular Contracture (CC) has been identified as the major cause of breast-implant failures and 
subsequent discomfort, pain and shape deformation following cosmetic breast implantation 
procedures. It has been documented that CC is primarily due to bacteria which are transmitted 
in the breast-cavity through conventional implantation. A ‘no-touch’ implant insertion technique 
has therefore been identified as the optimal method in potentially reducing CC rates. This 
describes an implant delivery without the implant ever touching: gloves (even during post-
insertion implant orientation assessments), retractors or the patient’s skin and breast-tissue; 
which is inherently unachievable with the traditional finger-manipulation method. To date, the 
most significant improvement in the insertion process has been a ‘minimal-touch’ technique, i.e. 
with the Keller-Funnel. This study was therefore in the design and development of a safe ‘no-
touch’ insertion device for the delivery of silicone breast-implants. Parameters included a 
horizontal 45 mm incision, which can stretch up to a maximum vertical central distance of 35 
mm. 
The proposed design featured a positive-displacement method with: (a) pressurized air as the 
insertion ‘force’, (b) an inverting-bag (partially inserted with the implant) to eliminate direct 
glove/implant contact, and (c) a built-in retractor with a breast-cavity air-removal path to reduce 
implant insertion resistance due to trapped air. The implant, in the device, remains closed to the 
environment and separated from the wound margin thus, eliminating skin/implant contact and 
further providing wound protection. Finally, the design employed an eccentric funnel shape for 
device use at the inframammary incision site with a suggested subpectoral or submuscular 
pocket placement, i.e. to eliminate breast-tissue/implant contact. Through experimentation with 
various implant sizes, device dimensions were suitable for implant-volumes up to 428.57 cm3. 
A 1 bar air supply was used to test the prototype and prove the concept on a silicone cast breast-
model. Leverage of the built-in retractor efficiently opened the incision for device placement 
multiple times and, the successful insertions of the implants and inverting-bag into the breast-
model indicated that a ‘no-touch’ technique was achievable. This was at a maximum insertion 
time of 4.2 seconds, amongst eight implants ranging from 242 to 428.57 cm3. However, the 
continued post-insertion air supply resulted in inflation of the inverted bag in the breast. This is 
at a high risk of developing a thoracic wall deformity and/or embolism. Suggestions were made 
to improve the design and eliminate this fault. 
The proposed ‘no-touch’ technique was successfully proven in vitro with significantly reduced 
insertion times. However, this is subject to breast-model evaluations and a greater insertion 
v 
 
resistance may be experienced in a real breast. The development of a device with an air supply 
safety cut-off and a sensitive air pressure transducer is recommended.  
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Capsular contracture (CC) has been the most common and persistent postoperative complication 
associated with breast implantation surgeries. This occurs when the otherwise normal formation 
of a fibrous capsule, around an implanted foreign object, tightens and squeezes the implant. The 
breast consequently becomes unnaturally hard, painful and distorted (Pittet, Montandon, & 
Pittet, 2005). Despite implant improvements, CC has continued to occur at high rates, often 
requiring corrective surgeries at increased risks and costs. The reported rate of CC occurrence 
has varied between 10-30% within the first five postoperative years (Mofid, 2011) and is 
estimated to be inevitable by the 25th year after implantation if there is no complication history 
(Grigg, Bondurant, Ernster, & Herdman, 2000). This is also at the risk of even higher 
reoccurrence rates following implant replacement treatments. 
While the etiology of CC remains unclear, investigations have strongly led to the ‘infectious 
theory’ (Pittet et al., 2005). This describes the primary cause of CC to be due to a bacterial 
multiplication process in the breast pocket environment, particularly with ‘skin’ bacteria which 
have gained access in the breast-cavity. A ‘no-touch’ implant insertion technique has been 
hypothesised as the optimal method in significantly reducing future complication rates thus, 
indicating a required improvement in the insertion process. By definition, the ‘no-touch’ 
technique refers to a direct implant insertion into the breast-pocket without the implant being 
touched by: instruments, drapes, gloves, or the patient’s skin and breast-tissue (Moyer, Ghazi, 
Saunders, & Losken, 2012). 
1.1.  Problem Statement 
To significantly reduce insertion related bacterial contamination in breast implantation 
procedures, increasing attention had been on the development of ‘no-touch’ breast-implant 
insertion devices. This stems from the inherent inability in achieving the required ‘no-touch’ 
technique with the traditional finger-manipulation method of insertion. Also inherent to the 
finger-manipulation method is the potential: (a) compromise to implant integrity (i.e. with 
regards to the implant shell and gel-structure) and (b) adverse effect on wound healing. This is 
due to the distribution of uneven forces on the implant and, the high degree of tissue trauma at 
the wound by the passing implant, respectively. To be surgically adopted, the use of a device is 
therefore required to significantly reduce complication rates and promote safer and faster 





requirements include: (a) implant integrity maintenance, (b) wound margin protection, and (c) a 
simple and easy to use design. 
To date the gold stand of devices, with a purpose to reduce the above stated complication, is the 
‘minimal-touch’ technique introduced by the Keller-Funnel (Moyer et al., 2012). This implant 
push-device (i.e. a device employing a positive implant displacement method) is the only device 
that has been introduced to market with the aim of reducing skin/implant contact, while 
providing a more even distribution of insertion forces to the implant. Due to the limitations 
introduced by the ‘minimal-touch’ technique of the Keller-Funnel, there exists a need for the 
design and development of a breast-implant insertion device that achieves a true ‘no-touch’ 
technique and meets requirements that will positively influence its appeal to the industry. This is 
particularly for the insertion of prefilled silicone-gel implants. 
1.2.  Aim and Objectives 
The aim of this study is to design and develop a silicone breast-implant insertion device that 
demonstrates (in vitro) the ‘no-touch’ technique and, is also conducive to safe implant and 
breast handling. To be surgically adopted, the proposed device design must be simple, easy to 
use and able to achieve the desired outcome in a timely manner. 
The objectives of this study (with in vitro visible evaluations) are therefore: 
1. To be able to insert prefilled silicone breast-implants through a 45 mm incision length that 
is stretchable (centrally) to a maximum perpendicular distance of 35 mm1. 
2. To eliminate skin/implant contact throughout insertion. 
3. To eliminate the need for an external retractor (to the device) to hold the incision open for 
implant delivery, i.e. for the elimination of additional surgical instrument contact on the 
implant surface.  
4. To eliminate direct glove/implant contact throughout insertion and (post-insertion) correct 
implant placement verification. 
5. To eliminate breast-tissue/implant contact prior to final placement. 
6. To demonstrate a safe positive-displacement method with regards to: 
6. a. maintaining implant integrity of the implant shell and gel-structure. 
6. b. safe breast handling. 
7. To be ergonomically conducive to the workable surgical space and overall handling of the 
device as an instrument at the incision site. 
                                                          





1.3.  Scope and Limitations of Study 
A major scope of this study is to bring forth and understand (from literature) the causes of CC 
which led to the current necessity worldwide to develop a ‘no-touch’ insertion technique. 
Thereafter, this study is in the design and development of a silicone breast-implant insertion 
device that visibly demonstrates a ‘no-touch’ technique and, also ensures in an atraumatic 
implant and breast handling delivery during breast implantation surgeries. This ‘no-touch’ 
technique is consequently, verified by the observations of silicone breast-implant insertions into 
a breast-model. Implant integrity is verified via post-insertion visible inspection of the implant 
for evidence of shell rupture and/or gel-fracture.  
This device is particularly designed for an incision length of 45 mm. It is therefore part of the 
scope to use the proposed insertion device to determine the maximum insertable implant volume 
for a 45 mm breast incision. Final device material selections and the ergonomics of prototype 
device assembly procedures, which do not influence the concept to be proven, are beyond the 
scope of this study.   
The limitations of this study are: 
1. The small sample-size of silicone breast-implants (donated to this study) which are 
composed of implants of varying: size, gel-type, shape and surface finish, introduce a 
number of variables which cannot be compared conclusively. This sample-set is also 
composed of both permanent and sizer breast-implants, which differ with regards to the 
thickness of the implant shells and cohesiveness of the gel. 
2. The ‘no-touch’ proof of concept will be limited to in vitro testing only and therefore, 
bacterial contamination testing will not be carried out. 
1.4.  Structure of Dissertation 
To fully determine design considerations and essential device features a background of the 
surgical procedure is provided, followed by a literature review on: the current body of evidence 
and understanding of CC, the traditional finger-manipulation method and, existing device 
designs. Based on these findings, device concepts are explored, critically analysed and followed 
by prototype development in the final design of the prototype. The proposed device concept is 








For centuries various attempts have been made to enhance the shape and size of the female 
breast. Surgical interventions became apparent in the 1880’s with the insertion of ivory, metal, 
glass and rubber implants. These insertions required painful procedures which often failed 
aesthetically and resulted in multiple medical complications (Sarwer, Nordmann, & Herbert, 
2000). The direct injection of materials such as petroleum jelly and silicone liquid (amongst 
others) into the breast-tissue were later introduced. However, complications remained severe 
and in some cases even resulted in breast loss or death (Grigg et al., 2000). The potential 
success and safety of breast implantation procedures only became apparent in 1963, following 
the invention of silicone elastomer shell implants filled with either a saline solution or silicone-
gel material (Sarwer et al., 2000). While the popularity of breast implantations have 
increasingly grown since the introduction of this type of implant, there remains a number of 
postoperative complication associated with the procedure (Tweed, 2003).  
This background provides an overview on the breast implantation procedure and associated 
postoperative complications. Prior to this, an overview on the popularity and an average patient 
description is provided.   
2.1. Popularity of Breast Implantation Surgery 
The use of breast-implants are the core components in breast augmentation and reconstructive 
surgeries for cosmetic enlargements (Grigg et al., 2000) and following mastectomies, trauma or 
development abnormalities (Fleming Fallon, 2013), respectively. In 2013, breast augmentation 
became the most popular cosmetic procedure performed by plastic surgeons worldwide, with 
over 1.7 million procedures reported to the International Society of Aesthetic Plastic Surgery 
(2014). This was a significant increase since the 1.2 million reported in 2010 (International 
Society of Aesthetic Plastic Surgery, 2011). South African statistics are not readily available 
however, trends in South Africa have been determined to follow closely to those reported in the 
United States of America (USA) (Finance Health Finance, 2013). As shown in Figure 2.1, 
despite a slight reduction during a recession period (i.e. between 2007 and 2009), a steady 
increase in these procedures have been observed in the USA (Smith, 2011). 
The number of breast implantation surgeries have continued to increase over the past ten years 
(Marcotte, 2013). In 2013, The American Society of Plastic Surgeons (2014) reported a total of 
290 224 augmentations, performed by their members. This represented a 1% increase since 





reported by these members in 2013, representing a 4% increase since 2012 and 21% increase 
since 2000. This supports the greater popularity of breast augmentations compared to 
reconstructive procedures (Rohrich, 2000). However, these totals are most likely an 
underestimate since; reported rates correspond to the procedures performed by the members of a 










2.2. Patient Description 
Improvements in technologies and subsequent decrease in costs has increasingly attracted 
individuals from less wealthy backgrounds to undergo these surgeries (Shaw, 2013). The 
average patient is of a middle to upper-middle socio-economic status (Sarwer et al., 2000). 
Breast implantation patients are primarily women however, in 2013, 12 reported augmentations 
were performed on  men in the United Kingdom (The British Association of Aesthetic Plastic 
Surgeons, 2014). Nonetheless, this patient analysis is with regards to the female patient. 
Both physical and psychological benefits have been observed in women following this type of 
procedure (Independent Review Group, 1998). According to the Independent Review Group 
(1998), the typical breast implantation patient is a women that: 
 Is dissatisfied with the shape and size of the natural breast (i.e. feelings of inadequacy). 
 Has a congenital defect or absence of one or both breasts. 
 Experienced a decrease in breast size after pregnancy or with increasing age. 
 Has undergone a mastectomy for treatment of cancer. 
 





The average augmentation patient is approximately 31 years of age and is often married with 
children (Sarwer et al., 2000). In 2013, according to The American Society of Plastic Surgeons 
(2014), augmentation patients were predominantly younger than reconstructive patients.  
2.3. Breast Implantation Surgery  
Prior to breast pocket dissection and implant insertion, preoperative surgical planning involving 
an evaluation of the patient’s breast-tissue, anatomy, desired physical outcome and preference is 
required. Collectively, these evaluations influence the surgical procedure (Allergan, 2009). An 
overview of the surgical variables and procedure is herein provided. 
2.3.1. Surgical Variables 
The surgical procedure is determined according to three variables, these include the chosen: 
 Implant type: filler material (saline/silicone); surface finish (textured/smooth); shape 
(round/anatomical); and size.  
 Implant pocket placement: subglandular, subpectoral or submuscular.  
 Incision site: periareolar, inframammary, transaxillary or transumbilical. 
Implant related (sub) variables are as indicated above. Of interest (at this stage) is the implant 
filler material, i.e. saline and silicone-gel. Unlike saline implants, silicone-gel implants are 
delivered prefilled (Hidalgo, 2000), so as to prevent gel-leakage concerns. Silicone-gel implants 
consequently require larger incision lengths and more time for insertion (Preissman, 2012). In 
retrospect, a silicone-gel implant can require incision lengths of up to 60 mm compared to 30 
mm for a saline implant of an identical final volume (Abell, Muhanna, & David, 2007). And, 
the associated increase in insertion times increases the procedure costs, as well as complication 
risk (Keller & Senn, 2013). In 2013, The American Society for Aesthetic Plastic Surgery (2013) 
reported the use of silicone-gel implants in 75% of augmentations, representing a 3% increase 
since the previous year (The American Society for Aesthetic Plastic Surgery, 2012). This has 
been determined to be due to the more natural appearance and softer feel of the breast with 
silicone-gel implants (Grigg et al., 2000). Unless otherwise stated, concern is with the insertion 
of silicone-gel implants and is herein referred to as silicone implants. 
An implant pocket is essentially created behind the breast-tissue or pectoral muscles (i.e. 
subglandular, subpectoral or submuscular pocket placements). Where, subpectoral is a 
combination of the subglandular and submuscular placements, and is often refer to as a dual-
plane placement (Hidalgo, 2000). Pocket plane selection largely depends on: the patient’s body 
type, amount of available soft tissue (for coverage) and, the specifics of the implant to be 





nerves are found between the breast-tissue and muscles. Consequently, submuscular and 
subpectoral pocket dissections tend to draw less blood (Camirand, Doucet, & Harris, 1999). 
However, the detachment and mobilization of muscles are required, which may 
(postoperatively) result in excessive pain and/or implant displacement with submuscular 
placements – due to the muscular compression on the implant (Spear, Bulan, & Venturi, 2004). 
Refer to APPENDIX A, Figure A.1 for an illustration of these placements.  
Incision site selection is based on the: size of the nipple, inframammary fold definition, 
presence of congenital breast abnormalities (tuberous breast) and  the need for a mastopexy 
(breast lift/reshaping) (Hidalgo, 2000). Regardless of the selected pocket plane, augmentations 
are ideally carried out through incision sites that will minimize the visibility of the resultant scar 
(Zochowski, 2014). There exists four potential incision sites (as shown in Figure 2.2) however; 
silicone implant insertions are not possible through the transumbilical site. There also exists 
implant control difficulties and potential placement inaccuracies with insertions through the 
transaxillary site (Hidalgo, 2000). The most frequently used site is the inframammary incision 
(Moyer et al., 2012). This accounts for between 70-80% of all breast implantation procedures 
(Arbor, 2013). Preference with this incision site is mainly due to: the simplicity and versatility 
of this site, greater control over implant placement, the reduced need for breast-tissue violation 
and effectively concealed incision lines (Spear, Bulan, et al., 2004). However, in the case of a 
simultaneous mastopexy, the periareolar incision is used for insertion (Jacobson, Gatti, 








2.3.2. Surgical Procedure 
After preoperative planning, an incision is made at the selected incision site, followed by 
dissection of the selected pocket plane. Traditionally, the implant is forced through the 
relatively small incision and into the breast-cavity with the fingers, whilst the rest of the hand 
 





applies pressure on the implant so as to prevent it from sliding back out (Abell et al., 2007) – 
this is the finger-manipulation method of insertion. Stainless steel retractor/s are used 
throughout insertion (and pocket dissection) to stretch and hold the incision open (Ledergerber, 
1998). Sizers may be used, prior to insertion of the permanent implant, to assist the surgeon in 
evaluating if the selected implant will achieve the desired surgical outcome, or if another 
implant size/type should be used (Adams, 2008).  
The average length of an augmentation procedure is between 1-2 hours (The American Society 
for Aesthetic Plastic Surgery, 2012). For silicone implants, insertions with the traditional finger-
manipulation method generally takes 5-15 minutes per an implant for even a highly skilled 
surgeon (Keller & Senn, 2013). This technique often becomes more difficult with larger 
implants and/or smaller incisions (Abell et al., 2007). Following insertion, the surgeon feels for 
correct implant placement and orientation with the tip of the fingers. Postoperatively, patients 
often have a drainage tube in place (for a few days) to drain any fluids that may have collected 
in the breast (Allergan, 2007). Figure 2.3 shows the insertion of a silicone implant through a 









2.4. Complications Associated with Breast Implantation Surgery 
Postoperative complications vary from mild to severe, all of which may result in reoperation 
combined with an implant removal (Tweed, 2003). Complications that are not medically related, 
but require reoperation, include: implant displacement, implant rotation, wrinkling/rippling and, 
discomfort or breast hardness due to an inadequate pocket dissection (Sarwer et al., 2000). 
These complications result in patient dissatisfaction and often are due to the inexperience of 












hematoma, clinical infection and capsular contracture (CC). These are local complications 
(Grigg et al., 2000).  
Reoperation following breast implantation has been reported in 17% of procedures within the 
first postoperative year (Moyer et al., 2012) and 25% after five years (Tweed, 2003). 
Considering the popularity of breast implantation surgeries, the risk of reoperation potentially 
affects a large number of women. In 2013 alone, The American Society of Plastic Surgeons 
(2014) reported a total of  23 770 implant removals (by their members) however, no indication 
was provided as to why these implants were removed. Nonetheless, a decrease in complication 
rates have been observed as the silicone breast-implant has evolved. There have been five 
generations of silicone implants since 1963 – each representing an attempt at further reducing 
complication rates. Changes in the manufacturing process of the implant have been with regards 
to the: shell, gel-structure and shape (i.e. from 1st generation smooth, round, high gel-bleed 
implants to 5th generation textured, anatomical and more form-stable cohesive gel implants) 
(Moyer et al., 2012). Where, gel-bleed refers to the diffusion of non-cross linked silicone 
particles through the elastomer shell, in the absence of a shell rupture (Pittet et al., 2005).  
The most common and persistent complication associated with breast implantation surgery is 
CC. This occurs when the otherwise normal formation of a fibrous capsule, around an implanted 
foreign object, tightens and squeezes the implant. As a result, the breast becomes unnaturally 
hard, distorted and/or painful (Pittet et al., 2005). The occurrence of CC, and the potential 
influence of the other local complications, is therefore of concern with this surgical procedure 








3. LITERATURE REVIEW 
To determine the design requirements for a breast-implant insertion device, this literature 
review investigates: the requirements for the prevention of capsular contracture (CC) and the 
inherent contribution of the traditional finger-manipulation method to this and other associated 
complications. This is followed by an analysis on existing insertion devices and essential 
aspects for prototype development. 
3.1. Capsular Contracture  
Within two to three weeks following implantation, the natural immune response results in an 
acellular and avascular collagenous sheath encapsulation of the implant (Mcgrath & Burkhardt, 
1984). This is a normal scar tissue which also forms around implanted cardiac pacemakers and 
orthopaedic prostheses (Pittet et al., 2005). A contracture is regarded as an abnormal 
progression of this natural immune response to the biologically inert and non-toxic breast-
implant. Physically, CC occurs when the scar tissue tightens and squeezes the deformable 
breast-implant into a hard spherical mass. This is in an attempt to reduce the implant surface 
area via a radial force (Camirand et al., 1999).  
Contractures have been observed to develop weeks to years after surgery, bilaterally or 
unilaterally, and to varying degrees of severity (Allergan, 2007). On average, between Ersek 
(1991) and Hipps, Raju, & Straith (1978), 50% of contractures have occurred unilaterally 
following bilateral implantations. The severity of a contracture is measured according to the 








Baker Classification Scale 
   Grade I – The implanted breast is as soft as a normal breast. 
   Grade II – The breast is not as soft and the implant can be palpated (but not visible). 
   Grade III – The breast is firmer and the implant can be easily palpated with visible distortion. 
   Grade IV – The breast is firm, tender, hard, cold, painful and distorted.  





This scale is entirely based on the appearance and feel of the breast (Grigg et al., 2000). Despite 
the inherent subjective nature of the Baker Grade system, this remains the most popular and 
practical method in externally assessing breast firmness (Tamboto, Vickery, & Deva, 2010). 
Baker Grade III/IV evaluations are generally considered as severe contractures (Grigg et al., 
2000) and, Grade II as mild, indicating the onset of a contracture (Marques et al., 2010). Figure 








3.1.1. Capsular Contracture Occurrence Rates 
The reported CC incidence has significantly varied between studies. 
 Manufacturers have reported the incidence of Grade III and IV contractures to be 
between 10-30% within the first five postoperative years (Mofid, 2011). 
 In literature this has ranged between 0-74% (Hester et al., 2012) and, 
 Between 0.6-100% of patients (Tamboto et al., 2010). 
This variation is primarily due to the anecdotal nature of most studies (Gabriel et al., 1997), 
refer to APPENDIX B.1, Table B.1 for other reported CC occurrence rates. While some studies 
continue to report high rates, contracture rates with newer 5th generation implants have 
reportedly been 6-times less than those reported with older generation (high gel-bleed) implants 
(Adams, 2009). A 100% contracture rate was also consistently reported following the injection 
of silicone-liquid into the breast (Grigg et al., 2000), see section 3.1.3.  
Approximately 90% of contractures have been reported between the first (Jacombs et al., 2012) 
and third (Ersek, 1991) postoperative year. The remainder of which have occurred more than 10 
years later (Adams, 2009), refer to Table B.2 for other reported time-to-contracture rates. It has 
been determined that, even in the absence of other complications, all implanted breasts will 
Figure 3.2: Baker Grade IV bilateral contracture (left)  (Pittet et al., 2005), right breast 






develop a severe contracture by the 25th postoperative year (Grigg et al., 2000). This indicates a 
progressive phenomenon (Sarwer et al., 2000). Consequently, the risk of CC development 
continues to exist as long as the implant remains in the breast (Jacombs et al., 2012). 
3.1.2. Potential Etiology of Capsular Contracture 
The exact cause of CC remains unknown (Preissman, 2012) however, studies have collectively 
indicated a multifactorial etiology (Adams, 2009). Factors that have been observed to influence 
CC development have included: 
 The type of surgery (augmentation vs. reconstructive) 
 Patient’s age at implantation  
 Chosen surgical variables (section 2.3.1) 
 Clinical infection 
 Hematoma 
 Gel-bleed (with/without shell rupture)  
With regards to the type of surgery, lower CC rates have consistently been reported with 
augmentation procedures (Adams, 2009), refer to Table B.3 for reported rates. While, 
reconstructive patients are generally older than augmentation patients, a more significant 
difference between the two types of surgeries is the increased surgical complexity required with 
a reconstructive procedure rather than the patient’s age at implantation (Handel et al., 1995). 
The influence of surgical variables on CC rates is illustrated in Figure 3.3. Regardless of the 
higher CC rates reported with silicone implants (Mckinney & Tresley, 1983), these remain the 
preferred type of prosthesis (section 2.3.1). With regards to surface-finish, texturing has been 
observed to delay CC development rather than reduce the occurrence  however, this advantage 
has been observably limited to subglandular placements (Handel et al., 1995). And, an increase 
in complication rates with volumetrically larger implants have been found (Somogyi & Brown, 
2015). Irrespective of the implant type, subpectoral placements have yielded even lower CC 
rates. However, the incision site has been determined to have the greatest impact on CC 
development (H. Becker & Springer, 1999), see section 3.1.4. In addition to the conclusive 
cautions associated with anecdotal studies, surgeons may also be more skilled with certain 
surgical variables thus, potentially influencing reported rates and observations (Handel et al., 
1995). Refer to Table B.4 – B.7 for reported CC rates associated to surgical variable selections. 
With regards to local complications, Sarwer et al. (2000) reported an incidence of 3% for both 
clinical infections and hematomas. While this occurrence may appear insignificant, this 









incidence of clinical infections and hematomas cannot compare to reported CC rates (Pajkos et 
al., 2003). Hematomas usually occur within an acute postoperative period (American Society of 
Plastic Surgeons, 2005) but have been determined to influence the risk of contracture by a factor 
of 2 (Mofid, 2011) and by a factor of 3 (Wixtrom, Stutman, Burke, Mahoney, & Codner, 2012). 
Hematomas have also been found to influence the occurrence of clinical infections (Courtiss, 
Goldwyn, & Anastasi, 1979). Hipps et al. (1978) reported that 86% of hematomas and 75% of 
clinical infections in their study later developed CC. It is likely that the reported incidence of 
infections and hematomas are an underestimate since, contractures are only recognized once the 
breast has already become firm. Furthermore, in keeping with CC occurrence, infection and 














The contribution of gel-bleed (with/without shell rupture) stems from the observed decrease in 
CC rates as the gel-filler has become more cohesive (section 2.4). Silicone implant shell rupture 
is usually absent of symptoms however, ‘loose’ silicone particles have reportedly produced 
similar symptoms to contractures (i.e. breast firmness, distortion and pain) (Allergan, 2009). 
This has created confusion between gel-bleed causing CC and CC contributing to shell rupture 
and gel-leakage. In either case there are ‘loose’ silicone particles inside the breast-cavity. 











Higher CC rates with silicone implant. 
Higher CC rates with smooth implants – 
when placed in the subglandular pocket 
plane. 
Higher CC rates with larger implants 
(>350cc) (Handel et al., 1995). 
Higher CC rates with subglandular. 
Highest CC rates with transaxillary, 
followed by periareolar (i.e. lowest CC rate 
with inframammary) (Jacobson et al., 2012). 





contractures with saline implants are attributed to the shedding of the silicone elastomer shell 
over time (Adams, 2009). 
Other factors that have influenced CC occurrence have also included: tissue trauma during/after 
surgery (Adams, 2009), the presence of talcum powder (from gloves) or any other irritants in 
the breast-cavity (Camirand et al., 1999) and, the surgeon’s technical skill (Jacobson et al., 
2012). To gain a better understanding of CC development, it is believed that the early 
inflammatory response on the cellular level may be the key to understanding the etiology of CC 
(Adams, 2009) and, potentially lead to innovative preventative solutions (Maxwell & Gabriel, 
2009). As a result, two theories have attempted to explain the development of contractures: the 
hypertrophic scarring and infectious theory (Pittet et al., 2005).  
3.1.3. The Hypertrophic Scarring Theory 
The hypertrophic scarring theory attributes the abnormal progression of the immune response to 
the presence of ‘loose’ silicone particles in the breast-cavity, i.e. gel-bleed. This presences was 
observed to directly influence the thickness of the capsule (Domanskis & Owsley, 1976) – as a 
result of an excessive collagen fibre deposition (Ersek, 1991). This theory was supported by the 
decrease in CC rates with saline implants and the progression of silicone implant generations 
(Siggelkow, Faridi, Spiritus, Klinge, & Rath, 2003). This also explains the 100% contracture 
rates reported with the injection of silicone-liquid into the breast (section 3.1.1) since, excessive 
gel outside the capsule has also been observed to develop lumps (Independent Review Group, 
1998). With regards to Baker Grade Classification, this theory therefore describes a direct 
relationship between CC severity and the thickness of the capsule (Domanskis & Owsley, 
1976). 
The capsule thickness and CC severity have been observed to increase with the implantation 
duration (demonstrating the progressive phenomenon of CC) but, severe contractures have not 
always shown evidence of thicker capsules compared to corresponding non-contracted capsule 
specimens (Siggelkow et al., 2003). This indicated a lack of correlation between capsule 
thickness and CC severity (Mofid, 2011). Furthermore, gel-bleed as a contributing factor does 
not account for the occurrence of unilateral contractures following bilateral implantations 
(Burkhardt, 1981). The decrease in CC occurrence with newer generation implants is therefore, 
due to the resistance of capsular compression by the more form-stable gel-filler material (Spear, 
Bulan, et al., 2004) hence, resulting in less firmness and lower Baker Grade evaluations. 
A more consistent finding with CC severity (and the associated increase in pain) has been the 
increase in: plasma cells, inflammatory cell infiltrates and fibroblast populations (Gayou, 1979). 





Burkhardt, 1984). The hypertrophic scarring theory is further contradicted by the reported lack 
of correlation between: inflammation and capsule thickness; and inflammatory cell infiltrates 
and ‘loose’ silicone particle presence (gel-bleed) (Siggelkow et al., 2003). Regardless, factors 
that influence capsule thickening are problematic since, the breast pocket is dissected according 
to the (exact) dimensions of the implant.  
3.1.4. The Infectious Theory 
The infectious theory attributes the progression of the immune response to the presence of a 
subclinical infection (Mofid, 2011). CC severity is therefore as a result of a subclinical bacterial 
multiplication process (Rieger et al., 2013), which is responsible for the increase in 
inflammatory cells (Pittet et al., 2005). This subclinical growth has been observed to be due to a 
biofilm formation around the implant, which is composed of multiple microorganisms 
embedded in an extracellular matrix (Tamboto et al., 2010). Once established, an antimicrobial 
resistant environment is created around the implant and the biofilm continues to thrive on the 
attachment of other bacterial species (Bartsich, Ascherman, Whittier, Yao, & Rohde, 2011).  
Biofilm formations have been reportedly responsible for approximately 80% of infections in the 
body (Wixtrom et al., 2012). With regards to CC, Coagulase-negative Staphylococci species, 
specifically Staphylococcus epidermidis, has been determined as the primary biofilm causative 
microorganism (Courtiss et al., 1979). S. epidermidis is naturally found just below the outer-
most layer of the skin (Adams, 2009). The breast ducts have also been found to harbour and 
extrude this bacterium into the surgical field thus, skin/implant contact and breast-tissue 
violation contribute to this bacterial contamination (Abell et al., 2007). Even after surgery, the  
breast ducts create a passage for bacterial seepage into the breast (Wixtrom et al., 2012).  
Other bacterial species also responsible for this biofilm formation include: Propionibacterium 
acnes naturally found in the sebaceous glands and on the skin (Bartsich et al., 2011) and, 
Bacillus species naturally found in the environment (Pajkos et al., 2003). Collectively, these 
bacterial species have potential access to the implant surface and breast-cavity throughout the 
procedure. The continuous rubbing of the implant against the skin frees the underlying bacterial 
species since, preoperative skin preparation only covers the outermost layer of the skin (Adams, 
2009). Surgical glove and instrument contact with the patient’s skin and breast-tissue (and then 
onto the implant) have also been determined as other sources of bacterial contamination (Abell 
et al., 2007). This bacterial development and growth of a subclinical infection, over prolonged 
periods, explains the progressive phenomenon of contractures (Mofid, 2011). The local nature 





Lehman, & Tan, 1981) however, an untreated contracture increases the risk of a thoracic wall 
deformity, i.e. pneumothorax (Asplund, Gylbert, & Jurell, 1990).  
Histologically, the contraction of the surrounding capsule is due to the modulation of active 
fibroblasts into myofibroblast (Domanskis & Owsley, 1976). The orientation of these 
myofibroblasts and collagen fibres in the capsule has been observed to influence capsule 
compression and therefore, contracture severity. Contaminated implants with severe 
contractures have featured densely packed concentrically orientated, thick bundles of 
collagenous fibres. And, non-contaminated implants have featured loosely packed parallel 
orientated components (Shah et al., 1981). This indicates a fibril orientation contribution to 
capsule contraction (Hester et al., 2012); however, the identification of myofibroblasts in both 
contracted and non-contracted capsules confirm that all capsules contract to some degree 
(Miller, 1981).  
This infectious theory for CC development has been further supported by the reported CC 
etiological agents (section 3.1.2), refer to Table 3.1. It is evident that clinical infections and 
hematomas contribute to the subclinical reaction. With regards to surgical variables, the reduced 
benefit of texturing following subpectoral placements is due to the greater benefit of a muscular 
barrier between the implant and the breast-tissue (Shah et al., 1981). This benefit is however 
short-lived following an incision that requires a passage through bacteria laden regions, i.e. the 
breast-tissue or sweat glands (H. Becker & Springer, 1999). In retrospect, the greater the degree 
of ductal system disruption the greater the amount of breast-pocket bacterial contamination 
(Jacobson et al., 2012), regardless of good surgical techniques (Wiener, 2008). The influence of 
trauma to the breast during/after surgery on CC development is therefore due to the spread of 
additional bacteria from the breast ducts, especially with subglandular placements (American 
Society of Plastic Surgeons, 2005). Furthermore, the occurrence of unilateral contractures 
following bilateral implantations significantly supports this theory – making systematic or 
implant related causes unlikely with regards to CC development (Rieger et al., 2013).  
The lack in permanent relief after treatment for CC has further supported the infectious theory. 
These treatment methods have included both surgical and non-surgical interventions. However, 
surgical interventions are usually required in the case of severe contractures (Pittet et al., 2005), 
refer to APPENDIX B.2 for an overview of CC treatment methods. Due to the strong bacterial 
attachment on the contracted implant and breast-cavity, the most widely recommended 
treatment is an implant replacement with a pocket change (American Society of Plastic 
Surgeons, 2005). CC reoccurrence rates have however been between 17.4% (Handel et al., 
1995) to 53.4% (Hester et al., 2012). This risk of reoccurrence also increases with repeated 





risk of additional complications such as: hematoma, infection, implant damage and malposition 
(Reid, Greve, & Casas, 2005). It is evident that CC preventative measures would be most 
advantageous (Mofid, 2011). Figure 3.4 shows the outcome of a capsulectomy following a 
severe contracture. 
Table 3.1: The infectious theory and potential CC etiological agents 
Etiological 
Agent 
Capsular Contracture influence – based on the Infectious Theory 
Clinical 
Infection 
Staphylococcus aureus is the primary bacterium cultured from clinical infection 
samples (Courtiss et al., 1979). This bacterium is also found on the skin (Bartsich 
et al., 2011) thus, clinical infections proceed sub-clinically, developing into 
contractures – even after treatment  (Wixtrom et al., 2012).  
Hematoma 
This rich source of iron is nutritional to the growth of biofilms and bacterium 
such as S. aureus (Wixtrom et al., 2012) resulting in CC and clinical infections, 
respectively. The drains required for hematoma removal also introduce additional 
bacteria into the breast-cavity (Hipps et al., 1978).  
Gel-bleed 
The higher CC rates with older generation implants are likely due to the more 
inadequate pocket irrigation solutions used in previous years. This is in 
conjunction with the capsule compression resistance offered by newer generation 
gel-fillers. Nonetheless, irrigation solutions still do not provide the required 
broad-spectrum coverage (Adams, 2009). 
Type of 
Surgery 
The higher CC rates with reconstructive procedures are due to the greater degree 
of breast-tissue manipulation and violation (Bartsich et al., 2011). 
Implant 
Type 
The higher CC rates with silicone-filled implants are due to the greater degree of 
skin/implant contact with the insertion of these prefilled implants (Embrey et al., 
1999). This also explains the higher CC rates reported with larger implants 
(Bartsich et al., 2011).  
Histologically, the lower CC rates with textured implants has been observed to be 
due to sample similarities with non-contracted capsules (Ersek, 1991). This 
observation also verifies the delay in CC development with textured implants 
since, orientation is related to the degree of contamination (Shah et al., 1981). 
Furthermore, smooth implant surfaces are more conducive to bacterial adherence 
(Embrey et al., 1999). 
Implant 
Placement 
The lower CC rates with subpectoral/submuscular placements are due to: the 
muscular barrier between the implant and bacteria laden ducts (Shah et al., 1981) 
and, better vascularity – an antibacterial benefit (Mcgrath & Burkhardt, 1984). 
This placement is also at the reduced risk of blood vessel dissection – conducive 
to hematoma prevention (Camirand et al., 1999). 
Incision 
Site 
The lowest CC rates with inframammary incisions are due to dissection and 
implant insertion travelling deep to the bacteria laden breast-tissue (Shah et al., 













3.1.5. Recommendations in the Prevention of Capsular Contracture 
Based on the infectious theory, CC development is evidently affected by the surgical technique 
more than implant related characteristics (Mofid, 2011). This has further been supported by the 
abandonment of preventative techniques that have aimed to alter the construction of the capsule 
around the implant – i.e. postoperative massage/expansion exercises (Allergan, 2009), steroid 
use (Hipps et al., 1978) and vitamin E consumption (Uzunismail, Duman, Perk, Findik, & 
Beyhan, 2008). In the prevention of bacterial contamination a number of recommendations to 
the traditional surgical procedure have been practiced and are described in Table 3.2. 
CC rates have reportedly reduced following the practice of these recommendations however, the 
risk continues to exist (Marques et al., 2010). This is due to the unavoidable bacterial 
contamination with the traditional surgical procedure. With reference to Table 3.2, the surgical 
gloves continue to transfer bacteria onto the implant from the skin and breast-tissue, even after 
insertion and with multiple glove changes (Moyer et al., 2012). The use of multiple retractors is 
also at an increased risk of bacterial contamination, due to the increased instrument/implant 
contact. The implant remains exposed to environmental bacteria throughout insertion and triple 
antibiotic irrigations still do not provide the require coverage (Adams, 2009). Consequently, CC 
prevention has remained a medical challenge (Mendes, Viterbo, & DeLucca, 2008). 
Considering pocket dissection relies on the surgeon’s technical skills (Table 3.2 – no. 4 & 10), 
increasing attention has been on the insertion process and the development of breast-implant 
insertion devices that will significantly reduce, if not eliminate, insertion related bacterial 
contamination (Moyer et al., 2012). While prevention of subclinical infections is of primary 
concern, CC remains an interplay between any factors that promote a foreign body reaction 
and/or local chronic inflammation (Spear, Seruya, Clemens, Teitelbaum, & Nahabedian, 2011). 
For a device to be surgically adopted, the proposed insertion technique must therefore address 
all other potential CC contributing factor, i.e. including the presence of ‘loose’ silicone particles 
 





in the surrounding capsule (Hester et al., 2012). This requires a thorough analysis of the 
traditional finger-manipulation method, prior to an investigation on essential design features for 
a device to achieve the desired insertion. 
Table 3.2: Recommendation to surgery – capsular contracture prevention 
 Recommendation to Surgery 
1 Limited implant handling 
and contact (with the skin 
and breast-tissue) 
To reduce environmental bacterial contamination, the 
implant is also only removed from the packaging and 
sterilized at the time of insertion (H. Becker & Springer, 
1999). 
2 Inframammary incision 
site 
Advantageously, this is the most widely used site (section 
2.3.1). In conjunction with a mastopexy, a second incision is 
recommended at the areolar, with insertion through the 
inframammary incision – indicating the significance of CC 
prevention over multiple scars (Wiener, 2008). 
3 Submuscular/Subpectoral 
placement 
However, this is largely patient dependant (section 2.3.1). 
4 Bloodless pocket 
preparation 
So as to prevent hematomas by achieving meticulous 
homeostasis (Wixtrom et al., 2012). A minimized dissection 
into the breast is also beneficial (Pajkos et al., 2003). 
5 Pocket irrigation with 
triple antibiotic solution 
This irrigation solution has observably achieved the greatest 
reduction in CC rates (Adams, 2009).  
6 Use of nipple shields This includes any method in the blockage of nipple leakage 
contamination during surgery (Wixtrom et al., 2012). 
7 Sterile surgical 
environment 
Skin sterilization (Adams, 2009). 
8 Glove change Due to extensive skin and breast-tissue contact on the 
surgeon’s gloves throughout pocket dissection, glove change 
is recommended with each insertion (Adams, 2009).  
9 Proper retraction during 
insertion 
So as to reduce skin/implant contact by keeping the wound 
open throughout insertion (H. Becker & Springer, 1999). 
The use of multiple retractors with several assistants has also 
been recommended (Bell & McKee, 2009).  
10 Quick procedures This has a direct impact on the degree of bacterial 
contamination. Longer procedures also adversely affect 
healing (Adams, 2009) and increase the cost of surgery 
(Keller & Senn, 2013). 
3.2. Analysis of the Traditional Finger-Manipulation Method  
The traditional finger-manipulation insertion method is analysed in terms of: the infectious 
theory (i.e. bacterial contamination.), potential ‘loose’ silicone particle sources (i.e. shell rupture 
and gel-bleed) and other adverse effects of this insertion method (i.e. implant shape deformation 





3.2.1. Bacterial Contamination 
The infectious theory describes a ‘no-touch’ insertion technique as the optimal method in 
effectively reducing bacterial contamination. Where, ‘no-touch’ implies a direct implant 
insertion into the breast-cavity without the implant ever touching: instruments, drapes, gloves, 
or the patient’s skin and breast-tissue (Moyer et al., 2012). This technique is unachievable with 
the traditional finger-manipulation method (Zochowski, 2014). The implant also remains open 
to environmental bacteria throughout insertion and, the insertion of sizers increase breast-cavity 
contamination prior to the placement of the permanent implant. It has been shown that proper 
tissue-based analysis and careful planning can reduce the need for Sizers in 99% of cases 
however, this is highly reliant on the surgeon’s skills (Adams, 2008).  
In an attempt to assist with the insertion of textured implants, the use of a BIOCELL Delivery 
Assistant Sleeve has demonstrated a ‘no-touch’ insertion (Castello et al., 2014). This sleeve 
protects the implant from bacterial attachments throughout insertion however, the rubbing of the 
skin and freeing of bacteria inherent to the traditional insertion method still significantly results 
in breast-cavity contamination, (refer to APPENDIX C.1). 
3.2.2. Shell Rupture and Gel-Fracture 
Silicone implant integrity refers to the integrity of the shell and gel-structure, damage to these 
components consequently result in shell rupture and gel-fracture, respectively (Moyer et al., 
2012) as shown in Figure 3.5. Compromise to the implant integrity is at the risk of a permanent 
implant shape deformation, adversely affecting the appearance of the breast and/or contributing 
to the presence of ‘loose’ silicone particles in the capsule. Advantageously, the presence of 
‘loose’ silicone particles is insignificant with 5th generation implants, even in the case of a 
















Shell rupture has been observed to occur following the development of a tear from an area of 
minor damage and, gel-fracture is as a result of the increased insertion difficulty with more 
cohesive gel-filled implants (Allergan, 2007). With regards to the traditional insertion method, 
the implant integrity is adversely affected by: 
 Uneven force distributions on the surface of the implant throughout insertion 
(Preissman, 2012), i.e. the excessive manipulation with extreme variability in finger 
pressure (Abell et al., 2007). 
 The forcing of an implant through too small of an incision length (American Society of 
Plastic Surgeons, 2005). 
 Sharp instrument and implant contact – specific to shell rupture (Preissman, 2012).   
In the maintenance of implant integrity, manufactures strongly recommend an even distribution 
of forces over the implant surface throughout insertion.  This is since highly localised stress on 
the implant has the potential to strain the shell past the point of elasticity, weakening the shell 
and making it more prone to gel-bleed and rupture. The increased difficulty with insertion of 5th 
generation implants also result in finger fatigue within a shorter period (Keller Medical Inc., 
2011). Implant shell wear over time (following a traditional insertion), is unavoidable and 
implant manufacturers recommend a replacement every ten years (Independent Review Group, 
1998). This has been supported by the reported average implant age of 11 years at the time of 
rupture. It is therefore evident that the traditional insertion method is not beneficial to long-term 
silicone implant integrity (Allergan, 2009). 
3.2.3. Wound Damage/Infection 
Inherent to the traditional finger-manipulation method is also the excessive frictional abrasion 
of the wound margin by the passing implant (more so with textured implants). This traumatizes 
the skin and occasionally causes the wound to tear, effectively increasing the scar length and 
risk of wound infection (Abell et al., 2007). Longer incision lengths are beneficial in preventing 
wound margin damage however, preference is with short incision lengths which promote faster 
healing and prevent unsightly scarring (Anderson & Hunt, 2014). In addition, the high 
coefficient of friction between the implant and stainless steel retractor is also a source of 
insertion resistance (Abell et al., 2007). 
3.2.4. Overall Required Improvements 
It is evident that the quality of the surgical technique delivered  by the surgeon is directly related 
to the overall success of the procedure; in that, the process determines: the patient’s experience, 





implantation procedures relies on: improved procedure safety, availability to more individuals, 
and advancements in technology (Rohrich, 2000). In addition to a ‘no-touch’ insertion 
technique (without breast-cavity contamination), an atraumatic implant delivery requires 
attention (Ledergerber, 1998). Quicker procedures (Keller & Senn, 2013) and minimal incision 
lengths are also desirable (Bracaglia, Gentileschi, & Tambasco, 2012).  
3.3.  Analysis of Existing Breast-Implant Insertion Devices 
The requirements for a breast-implant insertion device, as an improvement to the traditional 
finger-manipulation method, includes (from section 3.2): 
1. A ‘no-touch’ insertion technique (without the freeing of skin bacteria), requiring an 
elimination of: 
1.1 Direct glove/implant contact  
1.2 Skin/implant contact 
1.3 Breast-tissue/implant contact 
1.4 Instrument/implant contact 
2. An even distribution of insertion forces on the implant – to maintain implant integrity. 
3. Wound margin protection – to prevent wound damage/infection and implant resistance. 
4. A closed device – for protection from environmental bacteria. 
Other beneficial requirements for an insertion device also include (from section 3.1.5 & 3.2): 
5. Usability at the inframammary incision site.  
6. An elimination of direct glove/implant contact after insertion – which is required to feel 
for correct implant placement. 
7. Shorter insertion times – compared to 5-15 minutes (section 2.3.2).  
8. Shorter incision lengths. 
Amongst the attempts made in the design of insertion devices, none have successfully achieved 
all the above requirements or, in most cases, evidence of a successful insertion. Regardless, 
existing designs provide essential background for future developments. Based on the method of 
insertion employed, these designs feature either an implant push- or pull-device. Where, a push-
device briefly compresses (flattens) the implant and a pull-device briefly elongates the implant 
during insertion (Abell et al., 2007). While it is an objective (section 1.2) to design an implant 
push-device, implant pull-devices are also analysed for the purpose of determining design 
features that are essential to a successful insertion. Two pull-devices have been identified: 
propulsion (Abell et al., 2007) and suction from within the breast (Kairinos, 2011).  And, three  





and hand manipulation (Keller & Senn, 2013). The following analysis on existing insertion 
devices is with regards to the requirements listed above. 
3.3.1. Implant Pull-Devices 
Abell et al. (2007) proposed a propulsion system for the insertion of silicone implants, (refer to 
APPENDIX C.2.1, Figure C.2). This device features the use of a: flexible carrier-bag and, a 
rigid funnel with an attached winding cylinder and crank. Compared to the traditional finger 
method, this method of insertion is at an increased insertion difficulty – i.e. if insertion is even 
possible. As the implant is propelled into the breast, the carrier-bag consequently rubs against 
the wound margin. This action could also result in an early device detachment from the incision 
site. Nonetheless, the rigid funnel component is emphasised as the most appropriate shape in 
reducing the cross-sectional area of a prefilled silicone implant, for insertion through the 
relatively small incision length. This is at a larger inlet diameter compared to the outlet 
diameter, which is dimensioned to fit at a specified incision length. 
The suction system proposed by Kairinos (2011) featured a more conducive device shape for 
use at the inframammary incision site (section 3.3, no. 5), i.e. an eccentric funnel as 
demonstrated in Figure 3.6 & 3.7. While in vitro prototype testing was successful, immediate 
tissue collapse was observed following in vivo testing2. Nonetheless, the ‘built-in’ retractor of 
this device eliminates the need for external retractors (section 3.3, no. 1.4) and assists in device 
placement and attachment at the incision site thereby, also providing the required wound margin 
protection (section 3.3, no. 3). However, for the suction application, this featured ‘built-in’ 









                                                          
2 Information directly from A. Prof George Vicatos and Dr Nicholas Kairinos 
  
Figure 3.6: Implant Suction Device by Kairinos (2011) – everything to the left of the black dashed 
























Upon insertion, the tube through the built-in retractor with holes on the underside (Figure 3.6) 
also provides a natural air-removal passage, (for the air naturally occupying the breast-cavity 
after dissection). With the use of drains (without suction), Savaci & Tosun (2004) found that 
breast-cavity air-removal throughout insertion reduced implant insertion resistance 
consequently, reducing insertion times (section 3.3, no. 7) and incision lengths (section 3.3, no. 
8). While rare in surgery (National Health Service, 2013), inadequate air-removal throughout 
insertion is also at the risk of developing an air embolism in response to an increasing breast-
cavity pressure, a risk which increases with longer surgical procedures (Hsu, Basu, Venturi, & 
Davison, 2006). Traditionally, this air-removal would be achieved through gaps created by the 
external retractor between the implant and wound margin. An additional insertion device 
requirement is therefore: 
Breast-cavity air-removal throughout insertion – so as to reduce insertion resistance and 
prevent an air embolism occurrence.  
3.3.2. Implant Push-Devices 
The plunger system proposed by Shiao (1993) in a single use device, features a constant 
diameter injection barrel with a steep funnel towards the outlet of the device, (refer to 
APPENDIX C.3.1, Figure C.4). The implant is manually pushed through the device via the 
plunger (section 3.3, no. 2). This concept demonstrates a ‘no-touch’ insertion technique (section 
3.3, no. 1) with the implant closed to the environment (section 3.3, no. 4). However, a prefilled 
silicone implant insertion through the steep funnel at the device outlet may be difficult, 
simultaneously causing damage to the implant. It would be easier (requiring less manual force) 
to push the implant through a gradual decrease in cross-sectional area. Furthermore, following 
insertion, the expanded flaps in the breast are potentially at the risk of injuring the wound 
margin upon withdrawal of the device. In addition to the ergonomics of using the device, in the 
patent application by Shiao (1993) it was recommended that disposability of this device could 
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In an attempt to reduce insertion difficulty by providing an atraumatic implant delivery, 
Ledergerber (1998) proposed an insertion device that employs air/fluid to push the implant into 
the breast-cavity (section 3.3, no. 2) – refer to APPENDIX C.3.2, Figure C.5. It is evident that 
seals would be essential to prevent the air/liquid from escaping the device and entering the 
breast. This is achieved by the use of an expandable structure that fills with the air/liquid 
consequently, pushing the implant. This structure would be required to be appropriately durable 
and highly elastic however, the device walls are required to be inelastic. While it was not an aim 
to provide a ‘no-touch’ insertion, the implant is closed to the environment (section 3.3, no. 4) 
and, the wound margin is protected (section 3.3, no. 3) by a rigid collar at the incision site.  
The only device that has been successfully launched to market is the Keller-Funnel which 
employs hand-manipulation (opposed to finger-manipulation) to force the implant into the 
breast (Moyer et al., 2012). This is a compact disposable cone-shaped NYLON bag with a 
hydrophilic inner coating, (refer to APPENDIX C.3.3, Figure C.6). Due to the slippery inner 
coating and improved distribution of insertion forces (section 3.3, no. 2), use of the Keller-
Funnel has reportedly reduced: incision lengths (section 3.3, no. 8), insertion times to 3-20 
seconds per an insertion (section 3.3, no. 7) and, trauma to the wound/implant (Keller & Senn, 
2013). Preissman (2012) reported insertions of 500 cm3, 400 cm3, 550 cm3 and 400 cm3 
implants through periareolar incisions of 30 mm, 40 mm, 50 mm and 55 mm, respectively. 
However, no indication was provided regarding the type of gel contained within these implants 
(i.e. a soft/hard gel-filler), nor was there any indication regarding the surface finish and/or shape 
of these implants. These are relevant since, increased difficulties have been experienced with 
the insertions of textured and anatomical implants (Castello et al., 2014). Furthermore, Moyer et 
al. (2012) reported a ‘minimal-touch’ technique with the insertion of implants (ranging from 
300-600 cm3) through a 50 mm inframammary incision on a cadaver. This lack in a ‘no-touch’ 
technique has observably been due to: 
 An exposed portion of the implant at the device outlet (prior to insertion) – potential 
skin/implant contact (Moyer et al., 2012). 
 The required use of external retractors to hold the breast-cavity and incision open 
(Preissman, 2012). 
 Device handling difficulty (especially at the incision site). This is due to the slippery 
interior and lack of device attachment at the wound margin, i.e. slip of the device may 
result in skin/implant contact (Anderson & Hunt, 2014). 
In an attempt to address the required use of external retractors and the lack of device attachment 
at the wound with the Keller-Funnel, Anderson & Hunt, (2014) designed a rigid collar with 





site, followed by attachment of the collar and funnel, (refer to APPENDIX C.3.3, Figure C.7). 
Conversely, this collar with separate attachable retractors increases: the number of steps and 
complexity to the insertion process, the required assistance and the device thickness at the 
incision site. Nonetheless, a short retractor length is described as adequate for holding the 
incision and breast-cavity open; hence, allowing for an easier device removal after insertion 
(section 3.3, no.1.4). The rigidity of the collar also requires this component to be available in a 
range of sizes, dimensioned so as to fit at a specified incision length and to accommodate a 
range of implant-volumes. In contrast, the Keller-Funnel on its own is a one size fits all device, 
since the user cuts along indicia at the outlet to match a specific incision length and implant-
volume (Keller & Senn, 2013).  
Zochowski (2014) also described a range of features in the design of an insertion device that 
eliminates skin/ instrument/ and glove/implant contact. To achieve this, the primary focus was 
in the placement and attachment of the device at the incision site, (refer to APPENDIX C.3.4, 
Figure C.8). Of interest is the use of an inverting-bag to eliminate post-insertion direct 
glove/implant contact (section 3.3, no. 6). This bag, with the implant contained within, inverts 
about a plane of attachment as the implant and bag are inserted into the breast. For this 
application, the inverting-bag is required to be open at only one end. However, no indication is 
provided as to how this bag is attached to the device. 
It is evident that none of the existing insertion devices eliminate implant and breast-tissue 
contact throughout insertion. While the use of a ‘built-in’ retractor can open the breast-cavity 
and lift a portion of the breast-tissue, an inframammary incision site (section 3.3, no. 5) with a 
subpectoral/submuscular placement would be the most effective at reducing this contact (section 
3.3, no.1.3) – Table 3.2. 
3.4. Prototype Development 
The development of a ‘no-touch’ insertion device relies on features that eliminate the undesired 
implant contact, as well as other design aspects essential to a successful insertion as discussed in 
section 3.3. For the purpose of prototype development, a summary concerning breast-implant 
insertion and essential prototype aspects for an insertion device is herein provided. 
3.4.1. Summary 
1. Theoretically, the prevention of CC is in an elimination of breast-cavity and implant 
bacterial contamination, i.e. predominantly from skin and environmental bacteria. This 
also includes (to a lesser degree) factors that influence the thickening of the capsule 





2. With regards to surgical variables, the inframammary incision avoids bacteria laden 
tissue and has had the greatest impact on CC reduction. While pocket placement is 
largely patient dependant, the submuscular plane is also best suited to reducing breast-
tissue/implant contact. 
3. Increasing attention has been on the insertion process since; pocket dissection relies on 
the technical skills of the surgeon.  
4. Analysis of the traditional finger-manipulation method of insertion has revealed that 
bacterial contamination is unavoidable with this method. This insertion method is also 
at the risk of compromising implant integrity and, promoting wound infection due to 
the rubbing of the passing implant against the wound margin.  
5. Analysis of existing breast-implant insertion devices has revealed that a positive-
displacement method (implant-push device) is more conducive to a successful 
insertion. This is at the aid of either a hand-manipulation technique or fluid/air 
insertion pressure. These insertion methods also deliver the implant with a more even 
distribution of insertion forces on its surface. 
6. Essential insertion device features have include: 
 A gradually decreasing eccentric funnel shape, (to adequately reduce the cross-
sectional area of the implant for insertion through the relatively small incision 
length and for device placement at the inframammary fold). 
 A built-in retractor with a breast-cavity air-removal tube, (to open and hold the 
incision, to eliminate the use of additional external retractors and to remove the 
presence of air in the breast-cavity). 
 A closed device, (for implant protection against skin and environmental bacteria). 
 An inverting-bag, (to eliminate post-insertion direct glove/implant contact). 
 Placement and attachment of a rigid component through the incision site, (for 
wound margin protection). 
3.4.2. Essential Aspects of the Prototype 
It is evident from section 3.3, that a positive-displacement method is more conducive to a 
successful insertion. This is particularly following comparisons between the Keller-Funnel and 
the suction device by Kairinos (2011) which has been proven unable to achieve an insertion into 
the breast-cavity. The outlet of this suction device does however demonstrate an effective 
means of eliminating the need for an additional external retractor to open the incision. At the 
same time, although the proposed suction technique was not successful, the same holes that 
were meant to provide suction could also allow for a natural escape of trapped air in the breast 





other elements which will be developed in the prototype of this study include: aspects of an 
orifice at the incision site, fluid/air pressure as the positive-displacement method and an 




FINAL DESIGN OF THE PROTOTYPE 
4. FINAL DESIGN OF THE PROTOTYPE  
4.1. Design Statement  
As it was mentioned in the problem statement (section 1.1), the inability in achieving a ‘no-
touch’ insertion with the traditional finger-manipulation method has sparked various methods in 
designing breast-implant insertion devices. This is particularly for the insertion of silicone 
implants in breast implantation procedures. The limitations of existing insertion device concepts 
have yielded the need for the development of a single device that eliminates direct implant 
contact with: gloves and the patient’s skin and breast-tissue throughout insertion, as well as the 
need for additional external retractors. This device is also required to meet other requirements 
including: implant integrity maintenance; wound margin protection; safer and faster procedures; 
and a simple and easy to use design.   
4.2. Design Considerations 
The design considerations were established according to the analysis of the traditional finger-
manipulation method (section 3.2) and existing insertion device concepts (section 3.3). These 
considerations were subdivided into constraints, criteria (for surgical appeal) and requirements 
for a potentially successful ‘no-touch’ insertion. 
The requirements for a ‘no-touch’ insertion device and (potentially) applicable device features 
found in literature are tabulated and ‘cross-linked’ in Table 4.1. These requirements describe a 
‘closed’ implant push-device with a built-in retractor for: (a) device placement at the wound, (b) 
holding the incision and breast-cavity open and (c) providing a means for breast-cavity air-
removal upon insertion (via the built-in retractor). An inverting-bag is described as potentially 
effective in preventing post-insertion direct glove/implant contact. And, an eccentric funnel 
shape is described as suitable for the device usability at the inframammary incision site, this 
being the surgical variable evaluated as most effective in reducing bacterial contamination 
(section 3.1.5). 
In the design of the proposed device, the design constraints included: 
 The insertion of prefilled silicone implants. 
 Insertion through an incision length of 45 mm stretchable (centrally) a maximum 
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Table 4.1: Design features based on device requirements 
Device Requirements Design Features 
Insertion force 
direction 
An implant push-device A positive displacement mechanism via: 
 Hand manipulation 
 Plunger system 






Glove/implant contact An implant-holder that keeps the implant 
closed to the environment and skin throughout 
insertion. 
This includes protection against drawing freed 
‘skin’ bacteria into the breast-cavity. 
Skin/implant contact 
Instrument/implant contact A ‘built-in’ retractor able to: 
 Open the incision without assistance 
from additional external retractors. 
 Hold the breast-cavity open without 
assistance from external retractors. 
Breast/implant contact would be further 









contact after insertion 









Even distribution of 
insertion forces on the 
implant 
Implant push-device. Using: 
 Air/fluid pressure  
 Hand manipulation 
A low coefficient of friction between implant 
and device walls. 
Wound margin protection 
(due to friction at the 
wound) 
 
 A rigid device well fitted within the 
wound margin. 
 Well lubricated on the inside of the 





Breast-cavity air-removal Achieved via: 
 Drainage tubes 
 Holes on the underside of a ‘built-in’ 
retractor 
Frictional force between the 
implant and instruments 




Device usability at the 
inframammary fold 
 
Device able to rest on the torso and fit at this 
incision site – i.e. an eccentric funnel shape 
with a gradual eccentric-funnel angle. 
For the device to be surgically adopted the device criteria included: 
 A simple design that is easy to use (user-friendly), i.e. few operational steps; no more 
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 A safer and faster insertion method (shorter insertion times). 






4.3. Design Concept  
The device concept was developed according to the requirements and associated features 
described in Table 4.1. Various design concepts have been considered which ultimately led to 
the final concept described in this section.  
For the required positive implant-displacement method (objective no. 6, section 1.2), air 
pressure was chosen over hand-manipulation and a plunger system. This was since hand-
manipulation would essentially result in the design of additional components to the Keller-
Funnel (i.e. with a flexible implant-holder component) rather than the design of an entirely 
unrelated device, (refer APPENDIX D.1). It was also likely that the user may resort to the 
finger-manipulation method towards the end of the insertion process – so as to push the end 
portion of the implant through the device. And, the plunger system was evaluated as impractical 
since, the flat surface of the plunger (required to prevent point loads on the implant) was not 
conducive to the required funnelling of the device (section 3.3.2). Prior to insertion, the plunger 
also increases the length of the device which results in a bulkier device. Furthermore, it was 
predicted that a significant manual force may be required to push the implant with a plunger, 
(refer to APPENDIX D.2).  
Considering the essential device aspects identified in section 3.4, to achieve the desired 
insertion with an inverting-bag component and air as the insertion force, the proposed concept 
was made up of three designed components (herein referred to as: nozzle, mid-funnel and 
implant-holder), as shown in Figure 4.2. The steps for the operation of this device concept were 
as follows: 
1. The implant is placed into the inverting-bag. 
2. The inverting-bag with the implant is placed into the implant-holder. 







FINAL DESIGN OF THE PROTOTYPE 
3. The implant-holder is attached to the mid-funnel-component with the open end of the 
inverting-bag threaded through and wrapped around the outside of the mid-funnel-
component. 
4. The mid-funnel-component (with attached implant-holder) is attached into the nozzle-
component aided by the guide-knob and lock, consequently holding the inverting-bag 
against the Plane of Inversion. 
5. Once the components are securely attached to each other, the device is inserted through 
the incision site aided by the built-in retractor (with leverage at the device handle) until 
the device outlet securely lines the margin of the wound. 
6. The air supply is attached to the implant-holder and the push-button on the handle is 
used to control the air supply required to push the implant through the device. 
7. Following insertion, the mid-funnel-component is detached from the nozzle-component 
so as to release the inverted bag. 
8. The nozzle-component is removed (without pulling the inverted bag out). 
9. If the surgeon is required to feel for correct implant placement and orientation, the 
fingers are inserted through the inverted bag and into the breast-cavity – eliminating 
direct glove/implant contact.  
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Compared to the Keller-Funnel (section 3.3.2) the proposed concept is more complex in terms 
of its operation however, theoretically this design could be at a significant advantage with 
regards to the ‘quality’ of the insertion, i.e. a further bacterial contamination reduction (if not 
elimination) and wound margin protection. 
A closed device was essential for the application of air pressure – this was in addition to the 
benefits of a closed device with regards to bacterial contamination (section 3.3.2). This air 
supply would be blocked from entering the breast-cavity by the inverting-bag wrapped around 
the exterior of the mid-funnel-component (section 4.3, step no. 3), thereby, creating an air seal. 
The required breast-cavity air-removal (upon insertion) would however be achieved via the 
built-in retractor and out through the device handle as described in section 3.3.1. Due to the 
insertion of this retractor into the breast-cavity, it was also essential for the edges of the retractor 
to be rounded so as to prevent potential tissue trauma due to sharp corners. A short built-in 
retractor was determined as applicable to this design since; a longer retractor was more 
conducive to a suction system and increased device removal difficulties following insertion 
(section 3.3.2).  The device handle of this concept therefore had three functions: to maintain 
stability and device control (with leverage), to provide a breast-cavity air-removal passage and 
to provide the point of air supply control (push button). 
With reference to Figure 4.2, the requirement of the outlet of the nozzle-component was to 
match the elliptical shape of the wound (as shown in Figure 4.1). However, a circular profile 
throughout the device was evaluated as more conducive to simpler machining needs and 
component attachment methods, i.e. for threads, clips or bi-unit fittings. Consequently, the 
(required) elliptical outlet of the nozzle-component was designed to ‘loft’ towards a circular 
section at the Plane of Inversion and continued with circular sections throughout the remainder 
of the device. The insertion device also needed to rest on the patient’s chest for use at the 
inframammary incision. To address this requirement the circular sections were eccentric instead 
of following a right conical geometric configuration for the funnel (as demonstrated in Figure 
3.7). To hold the inverting-bag, the mid-funnel-component was designed to fit into the nozzle-
component thus, requiring both these components to be eccentric funnel shaped. Compared to 
living-hinge type pins (described in APPENDIX D.1), the fixed pins (on the mid-funnel-
component) were evaluated as a simple design conducive to device preparation (holding the bag 
and preventing it from slipping) and post-insertion inverting-bag release (see section 4.3, step 
no. 7).  
The guide-knob and pin on the exterior surface of the mid-funnel-component were designed to 
guide and lock this component into the nozzle-component, since rotation was not possible 
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paths on the nozzle-component. Following insertion, the guide-knob was required to be 
conducive to the detachment of the mid-funnel and nozzle components. Thus, a two-way guide 
was designed, which was more applicable than a bi-unit fitting (APPENDIX D.1) or one-way 
guide (APPENDIX D.3). The combination of the two-way guide and fixed pins on the mid-
funnel-component were therefore essential for an easy inverting-bag release (see section 4.3, 
step no. 7).  
The implant-holder was cylindrical having one end closed with a dome-shape cap, which 
features an attachment for the air supply. The internal diameter at the implant-holder delivery 
end was designed to match that of the mid-funnel-component inlet, since a smooth transition of 
the implant through the device was required. Due to this, rigidity was required at the ends of the 
implant-holder. Consequently, an implant-holder constructed from a fabric material (similar to 
the Keller-Funnel) was not conducive to this application, since a more complicated design 
would be required which also defeats the purpose of a compactable device with the use of fabric 
(APPENDIX D.4).  
The required device dimensions were determined prior to material evaluations for prototype 
development. Where, material evaluations were so as to verify device thicknesses according to 
the insertion air pressure and the selected material. The internal device dimensions were 
according to the required insertable implant-volume-range suitable for the 45 mm incision. And, 
a prototype development analysis was carried to determine final dimensions and function-
related features. 
4.4. Dimension Specifications  
Component dimensions were determined according to the required thickness and internal 
parameters of the prototype since, these parameters provided the device boundaries for 
insertions through the specified 45 mm incision (section 4.2). While the device was required to 
fit through the incision, the thickness of the device affected the outlet dimensions. To ensure an 
adequate implant volume-range was still insertable through the specified incision length, the 
outlet of the device was designed to resemble an incision of 40 mm – i.e. proportionally, 
stretchable (centrally) a maximum perpendicular distance of 30 mm (minor elliptical diameter). 
Device thickness was also partially specified for the nozzle and mid-funnel components 
according to functional requirements. 
At the author’s discretion, an eccentric-funnel angle,  of 38.63° (see APPENDIX E.1) was 
used, i.e. a gradual funnel (section 4.2). Based on this angle and the thickness requirements, the 
device parameters were defined according to the required implant-holder dimensions. An 
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4.4.1. Implant Evaluation 
To determine the diameter of the implant-holder, adequate of holding the implant without 
damaging it, a set of experiments were performed starting with a 50 mm (inner) diameter pipe 
and a 280 cm3 textured implant. As finger-manipulation was difficult and there existed a risk of 
tearing the implant against the sharp edges of the pipe, the implant was pulled into the pipe. 
Within a week following placement in the pipe, an implant failure was observed (i.e. rupture 
and gel-leakage). It was therefore evident that the implant-holder dimensions were required to 
be adequately sized according to an easy implant placement, into the device, by the user at the 
time of surgery. 
Consequently, to determine the required implant-holder parameters for a range of silicone 
breast-implants3, cylindrical ‘mock’-holders were constructed at varying internal diameters and 
lengths, as it is shown in Figure 4.3. The dimensions of the mock-holder suitable for housing the 
implants provided the required internal diameter and length of the implant-holder component. 
The internal diameters of these mock-holders were chosen to match potential diameters of the 
funnel-shaped mid-funnel-component, (refer to APPENDIX E.1). The mock-holders were 
constructed from 600 D polyester fabric which was glued to machined plastic rings. The internal 












While smaller implants easily fit into larger implant-holders, Table 4.2 shows the dimensions 
measured for the implant-holder according the implant volumes tested, (refer to Table E.1 for 
the specifications of these implants and implant-holder dimensions evaluated for each implant). 
                                                          
3 A total of 17 preliminary silicone-gel implants (ranging from 133.33 – 580.95 cm3) were received from 
Mr Craig McLuckie at Allergan Pharmaceuticals Ltd (Pty) in Midrand, Johannesburg. Refer to 
APPENDIX G.2, Table G.1, for the specifications of these implants. 
Figure 4.3: Implant ‘mock’ holders from a diameter of 70.5 mm to 90.5 mm 
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The appropriate implant-holder diameter was based on an easy hand manipulation of the 
implant into the holder and, the required length was based on allowing a small portion of the 
implant to stick out of the holder, at the author’s discretion. Device sizes for the 45 mm incision 
were classified according to the implant-holder size, from small to extra-large. 
 









(45 mm incision) 
Device size 
133 – 243 70.5 70 Small 
295 – 395 78.5 85 Medium 
428 – 467 82.5 90 Large 
500 – 581 90.5 100 Extra-Large 
 
4.4.2. Prototype Internal Dimensions and Size Classification  
To determine an appropriate insertable implant volume-range through the device, reported 
Keller-Funnel incision lengths (per implant volume-range) were used as a guide in the selection 
of the implant-holder size from section 4.4.1. This was since the Keller-Funnel has reportedly 
reduced bacterial contamination by 50% (section 3.3.2). Consequently, the Keller-Funnel was 
considered as the reference for implant-volumes and incision lengths. 
In section 3.3.2, it was reported that a 500 cm3 implant passed through a 30 mm periareolar 
incision with a Keller-Funnel insertion. However, there was no mention regarding the type of 
implant used. It was therefore assumed that such an implant must have been soft gel-filled or 
alternatively, a greater hand-manipulation force was exercised on the Keller-Funnel. This stems 
from the 400 cm3 implant insertion through a 40 mm incision that was also reported (see section 
3.3.2). 
The Keller-Funnel is a flexible NYLON bag while the prototype is an inflexible fixed-
dimension device, and due to the experiment described in section 4.4.1 with a 50 mm pipe, 
concerns about the integrity of the implant passing through a small outlet set the limit to a 40 
mm by 30 mm elliptical shape orifice. For these arguments and in order for the device to be able 
to deliver all types of implants (hard and soft gels) and in order to reduce the number of 
parameters in the experimentation, the prototype was designed according to the ‘medium’ sized 
device (Table 4.2). This was regarded as equivalent to the reported Keller-Funnel insertion of a 
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From Table 4.2, a 78.5 mm internal implant-holder diameter (length = 85mm) was determined 
as appropriate for the prototype. The required device dimensions were therefore determined 
from Figure E.1 according to the 78.5mm diameter. This described an internal device length of 
150 mm, i.e. from mid-funnel-component inlet to device outlet (65mm) plus implant-holder 
length (85mm – Table 4.2). These dimensions were assumed as conducive to the device 
application and surgical environment. 
The curve of the built-in retractor was determined according to the dimensions of the (medium 
device size) implant volume-range established in section 4.4.1. This shape is that of the implant 
inside the breast-cavity after insertion and it is assumed safe for both the implant and breast-
tissue. With reference to Table E.1, while the 395 cm3 implant was volumetrically larger than 
the 380.95 cm3, the base and projected contour dimensions of the 380.95 cm3 implant were 
slightly larger. Therefore, the dimensions used to model the built-in retractor were taken from 
the supplied specifications of the 380.95 cm3 implant, as shown in Figure E.2 (APPENDIX 
E.3). Due to the benefit of shorter built-in retractors with regards to post-insertion device 
removal (section 3.3.2) and suggestions from Dr N. Kairinos4, a 20 mm (horizontal length) 
retractor was regarded as sufficient for this prototype.  
The above dimensions and observations were used to guide the prototype design and 
development. 
4.5. Prototype Design and Development  
The aim of building the prototype device was to prove the concept described in section 4.3. 
Based on the dimensions described in previous sections, the mechanical properties of the 
selected materials were used to verifying the wall thicknesses of the prototype components 
under the application of a pre-selected air pressure.  
4.5.1. Prototype Design Concept 
In section 4.3, four basic components were discussed, which comprise the shape and 
functionality of the insertion device. These components (nozzle, mid-funnel, implant-holder and 
inverting-bag) are considered as the essential components of the device. The features and 
components that were not essential to proving the concept but were used for the purpose of the 
prototype design are described in Table F.1, APPENDIX F.  These are the specifications of: 
attachments between designed components; air supply control and related components (valve, 
electrical supply etc.); and the material of the inverting-bag. While the latter was not essential to 
                                                          




FINAL DESIGN OF THE PROTOTYPE 
proving the concept, the thickness of this bag influenced the required space between the nozzle 
and mid-funnel components. Thus, an inverting-bag for the purpose of the prototype was 
according to the following inverting-bag requirements: 
 Relatively thin, so as to allow the surgeon to adequately feel (through the bag) for 
implant wrinkles and correct placement. 
 Flexible, i.e. conducive to the required inversion. 
 Durable, with regards to the air pressure supply. 
 Inelastic. 
Due to the application of pressurized air as the positive-displacement force, components were 
designed having air seals between them. With reference to Figure 4.4, air seals were at: the 
circumferential taper around the mid-funnel and implant-holder components; a tightly held 
inverting-bag at the Plane of Inversion; and an NPT connection at the device inlet for the air 
supply attachment. To securely hold all the components together, strap handles on opposite 
sides of the nozzle-component were designed for an attachable strap to run from one handle, 
around the back of the implant-holder and to the other handle (Figure 4.4 (C)).  
4.5.2. Prototype Material and Other Necessary Parts Selection  
Material selections were required for the designed prototype components (nozzle, mid-funnel 
and implant-holder) and the inverting-bag. In addition to these essential components, a strap 
was used to hold the parts of the device together during experimentation. Also, in order to 
control the air supply standard pneumatic components were used such as, a valve and tubing. 
These are described in Table 4.4. Due to the aim of validating a breast-implant insertion device 
concept, the designed prototype components were developed from plastic materials, which were 
regarded suitable for the application at hand. Rapid prototyping with selective laser sintering 
(SLS) of fine powdered polyamide (NYLON 12, referred to as EOS PA2200)5 was selected for 
the development of the geometrically complex nozzle and mid-funnel components. High density 
polyethylene (HDPE) was selected for the development of the geometrically simpler implant-
holder-component. The engineering drawings of the individual designed prototype components 
and assembly of these components are shown in APPENDIX G.  
Prior to development, the wall thicknesses of the designed components and the thread 
attachment between the mid-funnel and implant-holder-component (Table F.1) were 
theoretically verified according to a pre-selected insertion air pressure. 
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Table 4.4: Materials/Parts selected for prototype device components 
Prototype 
Component 
Selected Material/Part Reason 
Nozzle Sintered Nylon12 Complex – rapid prototyping 
Mid-Funnel  Sintered Nylon12 Complex – rapid prototyping  
Implant-Holder HDPE Simple – standard machining 
Inverting-Bag Thin film polyethylene Bag requirements (section 4.5.1) 
Strap 
Polyester ‘seat belt strip’ with 
Velcro (stitched accordingly) 
To hold the prototype components 
together under the application of air 
pressure 
4.5.3. Thickness and Thread Verifications – Internal Pressure Related 
Calculations  
The air pressure, P, required for the insertion of the implant volume-range (section 4.4.2), could 
not be theoretically calculated. This was since implant properties were not available and 
extensive experimentation of these deformable implants would be required. It was assumed that 
a large insertion pressure may result in implant damage, device detachment from the wound and 
furthermore, it may be more difficult to maintain air seals and the speed of insertion. Therefore 
it was further assumed that 1 bar pressure would be suitable for the implant insertion. This 
pressure would provide an insertion force of approximately 484 N at the implant-holder internal 
diameter of 78.5 mm, (refer to APPENDIX H.1 for this calculation). Due to the application of 
air pressure, the wall thicknesses, t of the designed components (nozzle, mid-funnel and 
implant-holder) were verified according to pressure vessel analyses6, as well as the coupling 
M85 x 2  thread between the mid-funnel and implant-holder (Table F.1, APPENDIX F).  A 
safety factor (SF) 7 of 2 was used with pressure, P. 
For wall thickness verifications, a thin-walled pressure vessel analysis was applicable if the 
ratio of the internal diameter, d to t was larger than 20, as shown in equation 4-1. However, both 
the sets of thin- and thick-walled pressure vessel equations (4-2 to 4-5) were suited to 
cylindrical vessels. To account for the funnelling of the device, various sections of concern were 
determined and analysed as separate cylinders. These sections included the: internal maximum 
(Ø 78.5 mm) and minimum (Ø 34.5 mm) diameters (Figure E.1); the elliptical device outlet; and 
the ellipsoidal end cap of the implant-holder.  
For a thin-walled cylinder: 
   𝑑
𝑡
 ≥ 20       (4-1) 
                                                          
6 From: Strength of Materials for Technicians (Drotsky, 2011). 
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                TS = 
(𝑝×𝑆𝐹)𝑑
2𝑡




 (elliptical profile and end-cap8)                (4-3) 
For a thick-walled cylinder: 
     r = C - 
𝐵
𝑟2
 and c = C + 
𝐵
𝑟2
  (circular profile)          (4-4) 
              r = C - 
𝐵
(𝑎 × 𝑏)
 and c = C + 
𝐵
(𝑎 × 𝑏)
 (elliptical profile)      (4-5) 
The tensile strength, TS of the concerned materials is shown in Table 4.5. To determine the 
constants C and B, these stress equations (4-4 and 4-5) were evaluated at the inner, i and outer, 
0 radii of the components at the relevant sections of concern – with ro = 0 and ri = p × SF. 
Table 4.5: Tensile strength properties of sintered NYLON 12 (PA2200) and high density 
polyethylene (HDPE) 
Material Tensile Strength, TS 
(MPa) 
Sintered PA22009 45 ± 3 
HDPE10 32 
 
In the case of a thin-walled vessel, the minimum required t due to the 1 bar insertion pressure 
was determined and compared to the designed thickness. For a thick-walled cylinder, the 
internal circumferential stress, ci was determined and compared to the TS of the selected 
component material. These results are shown in Table 4.6 for each sections of concern, with the 
detailed calculations in APPENDIX H.2. It was evident in all cases that the minimum required 
thicknesses were significantly lower than the designed thicknesses and, ci were lower than TS 
of the concerned components. Thus, verifying that the designed thicknesses for prototype 
development were sufficient to withstand the forces due to air pressure.  
To verify the M85 × 2 threads, the maximum allowable internal pressure, Pmax of this type of 
thread and for HDPE (Table 4.5) was determined according to equations 4-6 and 4-7.  
For thread calculation at M85 × 2 (HDPE): 
    At = 
𝜋
4
[𝐷𝑡 – (0.938194 × 𝑃𝐶𝐷)]
2                (4-6) 
                                                          
8 From: Analysis of Heads of Pressure Vessels (Lawate & Deshmukh, 2015).  
9 From: (Electro Optical Solutions, 2004) – as supplied by CPRM 
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           TS = 
𝐹
𝐴𝑡
 = (𝑃 ×𝑆𝐹)𝐴
𝐴𝑡
      (4-7) 
It was found that the calculated Pmax of almost 18 MPa was significantly larger than the 1 bar (1 
× 105 Pa) insertion pressure, (refer to APPENDIX H.3). Thus, verifying that the threaded feature 
will withstand the applied forces. 











Ø 78.5 mm 
Mid-Funnel 2.9 26.9 Thin-Wall Min. Thickness = 0.174 mm 
Implant-
Holder 
3.25 24.2 Thin-Wall Min. Thickness =  0.245 mm 
Ø 34.5 mm Mid-Funnel 2.9 11.9 Thick-Wall 
ci = 141.56 Pa  
Which was significantly 
below TS = 45 MPa  
Device outlet: 
a = 20 mm 
 














Min. Thickness =  0.0593 mm  
 
ci = 133.35 Pa  
Which was significantly 





4 20 Thin-Wall Min. Thickness = 0.241 mm 
 
4.5.4. Prototype Development   
The built prototype was as shown in Figure 4.4 (C). Deficiencies in the prototype device were 
however observed and these were specific to the NYLON SLS manufactured components (i.e. 
nozzle and mid-funnel). This was with: (a) the blockage of the air-removal path by trapped 
loose NYLON powder and (b) the roughness of the surface of these components even after 
tumbling.  
A flexible wire was pushed through the air-removal path from the tip of the retractor. According 
to Figure 4.5, a purposefully designed exhaust hole allowed any blockage due to trapped 
powder to be cleared11. This hole however, does not interfere with the passage of the implant 
and it is covered by the inverting-bag as it passes through the outlet. For the purposes of the 
prototype development, it was experimentally determined (see section 5.2) that an appropriate 
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lubricant on the internal walls of the device components would effectively reduce the frictional 










This prototype, with lubrication and an air supply, was therefore regarded as suitable for 
determining if the proposed concept (section 4.3) achieves the objectives of this study. This 
evaluation would however rely on an in vitro test that closely resembles the female breast and 






                                                          
12 Two lubricants were used: K-Y Jelly and petroleum jelly. NYLON is chemically stable with both of 
these lubricants (Electro Optical Solutions, 2004). 
Figure 4.5: Cross-sectional view at the junction of the breast-cavity air-removal-tube from 








5. EXPERIMENTAL INVESTIGATION 
5.1.  Objectives of Investigation 
To prove (in vitro) the proposed ‘no-touch’ breast-implant insertion device concept (section 
4.3), the investigation objectives for the medium device sized prototype (section 4.5) included: 
1. A verification of the pre-selected 1 bar (gauge) insertion pressure (section 4.5.3).  
2. Face validations of a safe ‘no-touch’ insertion into a silicone cast breast-model, with an 
elimination of post-insertion direct glove/implant contact, and which was verified by a 
plastic surgeon.  
5.2.  Insertion Air Pressure Verification – Plunger Test 
For the verification of the 1 bar insertion pressure, a plunger test was used to determine the 
maximum force required to push implants passed the funnel section of the device. With this 
plunger test experiment, medium and small sized implants (Table 4.2) were tested for: (a) the 
adequate force to push the implant through the device, (b) surface lubrication and type of 
lubricant and (c) integrity of the implant passing through the device.  
5.2.1. Test Setup and Process 
A plunger with a platform for the placement of mass pieces was constructed for this test, as 
shown in Figure 5.1. The total weight of the mass pieces required to push any particular implant 
was used to determine the required force. 
For this test, the device components were lubricated with K-Y Jelly (as mentioned in section 
4.5.4). This was followed by preparation of the device as described in steps 1 to 4 of section 4.3. 
The inverting-bag was also included in this preparation of the device but, this was only for the 
purpose of conformity and not to observe if the desired inversion of the bag was achievable. The 
prepared device was supported upside-down and multiple mass pieces of 5, 10 and 19 kg were 
placed as needed on the mass-piece-platform (Figure 5.1). This was performed until movement 
of the plunger was observed and again if the plunger stopped moving before reaching the end of 
the stroke. The results are shown in Table 5.1. 
Due to the limitations of a plunger with a funnel shaped device (described in section 4.3), the 
implants were not expected to completely pass through the outlet during this test. An evaluation 
of the modelled insertion device showed that the funnelled region had a volume13 of 156.2 cm3, 
consequently an equivalent volume was expected to remain in the device after the plunger 
                                                          





reached the end of the stroke. This is also evident in Figure 5.1 with only a portion of the 
implant observed through the device outlet. The implant was removed by pulling it out of the 
device, something that partially damaged the implants during this experiment (see Figure 5.2 












The above mentioned process was repeated for each implant in this experiment. This included a 
total of seven implants (three from the small device-range and four from the medium device-
range) as listed in Table 5.1. The implants that required the largest mass to be pushed through 
the device were used to calculate the required insertion air pressure. 
5.2.2. Results and Observations 
From Table 5.1, the largest required mass, mreq, to move the plunger to the end of stroke was 49 
kg and was recorded for implants no. 10 (357.14 cm3) and no. 11 (380.95 cm3). Using equations 
5-1 and 5-2 with this mass of 49 kg, the required insertion pressure was evaluated to be 
approximately 1 bar. Thus, verifying that the pre-selected 1 bar air pressure (section 4.5.3) 
would be sufficient for the implant insertions through the prototype device. Refer to 
APPENDIX I.1, Table I.1 for necessary constants and Table I.2 for the calculated insertion 
pressure of each implant in the plunger test. 












     FT  =  (mreq × g) + Wp      (5-1) 
                                       p  =  𝐹𝑇
A
                    (5-2)  
















l 1 Textured Mod. Hard 133.33 Anatomical 10 10 seconds 
5 Smooth Mod. Soft 180.95 Round 35 20 seconds 





 9 Smooth Mod. Soft 295.24 Round 40 1.5 minute 
10 Textured Very Soft 357.14 Round 49 30 seconds 
11 Smooth Mod. Hard 380.95 Anatomical  49 3 minutes 
12 Smooth Mod. Soft 395 Anatomical 29 30 seconds 
 
From Table 5.1, it is also evident that mreq for implant no. 12 (395 cm3) was less than all the 
implants in the medium device-range, as well as implants no. 5 (180.95 cm3) and no. 7 (238.10 
cm3) of the small device-range. While a comparison between mreq of implant no. 11 and 12 are 
in keeping with the reported increase in insertion difficulties with harder gel-filled implants 
(section 3.2.2), theoretically mreq for implant no. 12 should not have been smaller than that of 
implant no. 10 (with a very soft gel-type) and no. 5 (with the same gel-type). A plausible 
explanation for this discrepancy was therefore in a greater (unintentional) amount of device 
lubrication used in the testing of implant no. 12, or that no. 12 was a sizer implant which tends 
to have a thinner, more deformable shell. Due to the damage caused to the implants by the 
pulling of the implants out of the device through the outlet (following the end of the stroke), this 
result could not be further verified with repeated plunger tests. The only way to remove the 
implant out of the device after the end of the stroke was by physically pulling it out. However, 
this had caused undesirable damage to the implants, specifically with implant no. 9, 11 and 12 
which had shown shape deformation and gel-fracture, refer to Figure 5.2 and I.1 (APPENDIX 
I.1). The plunger test results and insertion pressure verification were therefore limited to one 
round of testing. 
Other prototype-related observations were with regards to the:  
1. Placement of the implant in the implant-holder. 
It was observed that in coupling the mid-funnel to the implant-holder (with a screw fitting), the 





outlet of the device was essential during device preparation, since this would directly affect the 
post-insertion orientation of the implant in the breast-cavity. 
2. Use of K-Y Jelly directly on the NYLON components. 
The thin water-based K-Y Jelly was not sufficient for the roughness of the NYLON 
components. In subsequent tests, a petroleum jelly lubricant was directly applied on the 
NYLON components and followed by a layer of water-based K-Y Jelly. This combination 












5.3. Prototype Evaluation – In Vitro Breast-Model Test 
For the face validation of the proposed insertion technique, a breast-model test was used to 
observe insertions with the medium device sized prototype. This was according to the visible 
observation (and feel) of a safe ‘no-touch’ insertion, an elimination of post-insertion direct 
glove/implant contact and the ergonomics of the device. A successful insertion was therefore 
achieved if the implant was inserted into the breast followed by the required inversion of the 
inverting-bag. And, a safe insertion was indicated by the maintenance of the implant integrity 
and the reaction of the breast-model to the insertion. The specifications and development of the 

















Figure 5.2: Condition of the implants in the plunger test subset after being manually 





5.3.1. Breast-Model Specifications and Development 
For a reliable in vitro test, a portion of a female torso (breast-model) was required to closely 
resemble a human (female) breast with a breast-cavity. The breast-model requirements therefore 
included: 
1. A 45 mm inframammary incision able to be stretched as shown in Figure 4.1. 
2. Breast-cavity dimensions suitable for the placement of all the implants in the medium 
sized device-range (Table 4.2). 
3. An air-tight breast-cavity. 
The breast-model was constructed by the casting of a silicone material referred to as Dragon 
Skin®30. This followed from the evaluated suitability of this cast material for the development 
of face validation models14. Where, face validation is for the purpose of visible observation and 
‘feel’, and not for the purpose of biomechanical tissue investigations15. This Dragon Skin®30 
silicone could also be stretched from a 45 mm incision to the specified open (stretched) incision 
dimensions (requirement no. 1, above). Thus, the open (stretched) incision dimensions were 
more essential to this model than the exact matching of the material properties to that of human 
skin around the breast area. 
To ensure all the implants in the medium sized device-range (requirement no. 2, above) were 
insertable into this model, the breast-cavity was dimensioned according to the implant with the 
largest base and projected contour in this range, i.e. implant no. 11 at 380.95 cm3 (Table E.1). 
This was since the silicone material was not conducive to the required ‘stretch’ if this breast-
cavity was constructed similar that of an empty real dissected breast-cavity prior to an implant 
insertion16.  
To ensure an air-tight breast-cavity (requirement no. 3, above), access to the breast-cavity was 
limited to the incision at the inframammary fold. Consequently, for post-insertion implant 
removal from the breast-model, the implant was required to be pulled back out through the 
inframammary incision.  The developed silicone cast breast-model with the prototype device 
placed through the incision site is shown in Figure 5.3. 
The breast-model visibly resembled a female breast and the incision could be stretched to 
accommodate the placement of the prototype (outlet). This breast-model was therefore regarded 
                                                          
14 Used in the development of surgical training models (Cheung, Looi, Lendvay, Drake, & Farhat, 2014). 
15 Where, the mechanical properties of Dragon Skin®30 has been better suited to modelling epithelial 
tissue (Murray & Thomson, 2010) and muscular tissue (Sparks et al., 2015). 
16 Information provided by Prosthetic Artist, Miss Elani Allers – to whom the development of the silicone 





suitable for the face validations of the proposed concept. In order to repeat the experiment with 
the same size implant, the implant had to be removed by pulling it out through the incision. This 










5.3.2. Test Setup and Process 
For the prototype evaluation, insertions of eight implants into the breast-model were observed. 
Implants were supplied for this test by Allergan17, but due to their cost, only one of each size 
was made available. However, implants no. 11 and 12 (Table 5.1 in section 5.2), which were 
used for the plunger test, were reused and therefore not new during the breast-model testing. 
Upon request, three additional implants (no. 18, 19 and 20) were received. While the implant-
holder was designed to accommodate implant sizes up to 395 cm3 (the decision made during the 
design stage of the device), it was found during experimentation that implant sizes of 400 cm3 
and 428.57 cm3 could also be accommodated and therefore, were included in the testing. Table 
5.2 shows the range of implants that were tested. 
Device components were first lubricated as described in section 5.2.2 and assembled as 
described in steps 1 to 4 of section 4.3, ensuring at the same time that the orientation of the 
implant in the assembled device was correct. The components were then securely held together 
(for the purpose of the prototype) by a strap (Figure 4.4 (C)).  
                                                          
17 From: Allergan Pharmaceuticals Ltd (Pty) in Midrand, Johannesburg. 
 














8 Textured Mod. Soft 242.86 Anatomical 
18 Smooth Mod. Hard 270 Anatomical 
Medium 
19 Textured Mod. Soft 295.24 Round 
10 Textured Very Soft 357.14 Round 
11 Smooth Mod. Hard 380.95 Anatomical 
12 Smooth Mod. Soft 395 Anatomical  
 20 Smooth Mod. Hard 400 Anatomical 
Large  13 Textured Very Soft 428.57 Round 
 
The air-supply (set at 1 bar by the pressure regulator valve) was attached to the device as shown 
in Figure 5.4, and the outlet of the device was inserted through the inframammary incision of 
the breast-model as shown in Figure 5.3. The 1 bar air supply was passed through the device 
inlet until the implant had been inserted into the breast-cavity. An insertion was achieved 
according to one of two criteria: (a) the device felt empty (i.e. lighter by weight) or (b) the 
breast portion of the model was observed to have expanded. The insertion time was recorded 
















valve outlet  
pipe (i.e.  
air supply at 1 bar) 
valve inlet 
pipe carrying 
air at 1 bar 
pressure 
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Figure 5.4: Prototype device setup prior to placement at the breast-model incision (the 





Following insertion, the prototype device was further evaluated according to steps no. 7 to 10 of 
section 4.3. Finally, the inserted implant was removed from the breast-model (as described in 
section 5.3.1) and inspected for any visible damage. This testing method was repeated for three 
successful insertions per implant.  
5.3.3. Results, Observations and Discussions 
The experimental procedure in vitro using the breast-model was particularly addressing the 
efficacy of the prototype conceptual design in using air to propel the implant through the outlet 
of the device into the breast-cavity, and concurrently to maintain no-touch conditions of the 
implant. Therefore, the data collected and the observations made address the following issues: 
1. Time taken for the implant insertion. 
2. Successful/not successful inversion of the inverting-bag and integrity of the inverting-
bag (essential to the no-touch condition). 
3. Ability to smooth the implant (and verify correct placement) in the breast-cavity 
through the inverting-bag and integrity of the implant after insertion. 
4. Ergonomics of holding and manipulating the device. 
5. Reliability of the procedure as a simulated surgical technique. 
5.3.3.1. Insertion Times 
The insertion times were recorded in Table I.3 (APPENDIX I.2) and are in Figure 5.5. On 
average, the insertion time for successful insertions in this test varied from 2.5 to 4.2 seconds. 
However, this timing has not been verified in vivo and therefore, cannot be used as a 
comparative measure with other devices.  
5.3.3.2. Inversion and Integrity of the Inverting-Bag 
During the first experiment, it was observed that the inverting-bags18 tore and although the 
implants were inserted, the inverting-bag remaining in the device torn. Subsequent tests were 
performed with a thicker inverting-bag19 but although it was inverted inside the breast-cavity, 
even these were found to be torn. The tearing was attributed to the air pressure, as a ‘pop’ sound 
was heard during insertion.  
A total of 30 insertion attempts were made (Test 1: 12 attempts; Test 2: 9 attempts; Test 3: 9 
attempts). In test 1, the thin inverting-bag was used and four attempts were unsuccessful due to 
bag rupture prior to implant insertion. In tests 2 and 3, the thicker inverting-bag was used and 
                                                          
18 0.05 mm (thick) polyethylene bag. 





one attempt in each of tests 2 and 3 were unsuccessful due to bag rupture prior to implant 
insertion. In all the remaining 24 tests the inverting-bag was found torn in the breast-cavity and 
this was also attributed to the air pressure. Refer to Table I.3 for details on these inverting-bag 
tears. 
 
Figure 5.5: Bar graph showing silicone breast-model test results for all the successful 
insertions 
5.3.3.3. Implant integrity 
Post-insertion inspection revealed that implant no. 10 was inserted upside-down and no. 12 was 
orientated incorrectly. However, this was only observed with Test 1 insertions, after which 
adjustment to the assembly procedure of the device eliminated this problem. In all the tests in 
which inversion of the inverting-bag was successful the smoothing of the implant inside the 
breast-cavity was performed by a plastic surgeon (Dr N. Kairinos) who verified that: (a) the 
implant was orientated correctly and (b) that the no-touch condition procedure was successful. 
It was also ascertained that apart from the already damaged implants no. 11 and 12 during the 
plunger test (see Table I.2) all other implants for all Tests 1, 2 and 3 were minimally damaged, 
not due to insertion but during implant removal from the breast-cavity. The damage was 
localised at the areas where the implant was squeezed past the relatively harder-than-human-
tissue, silicone material of the breast-model, and of course due to the tight grip necessary to pull 
the implant out of the breast-cavity. The reuse of the implants did not affect any parameters of 



































5.3.3.4. Ergonomics of the Prototype Device 
While one of the indicators for the implant insertion was a slightly expanded breast, it was 
observed that a continued air-supply after insertion excessively expanded the silicone breast, as 
shown in Figure 5.6. This expansion was initially assumed to be due to a possible blockage of 
the retractor air-removal holes by the passing implant, as demonstrated in Figure 5.7. However, 





















Figure 5.6: Excessive expansion of the silicone breast-model due to a continued 
air supply following insertion 
 
Figure 5.7: Observation of the passing implant through the prototype. (Red 





To determine if the blockage of the air-removal-path was responsible for the observed breast 
expansion, a drainage tube was inserted alongside the prototype device through the incision site. 
During insertion a minimal amount of air flow was felt through the drainage tube. This 
indicated that air from the air-supply did not enter the breast-cavity, since this air would have 
otherwise exited the breast through the drainage tube. Considering that the inverting-bag entered 
the breast-cavity too, the breast expansion was therefore confirmed to be due to the inflation of 
the inverted bag in the breast-cavity. This indicated a deficiency of the device to control the air 
supply, an issue which will be discussed in section 6.  
Apart from the above issue against the functionality of the device, ergonomic related 
observations of the prototype included: 
 The thread attachment between the mid-funnel and implant-holder components was not 
suitable to ensuring a correct implant placement in the assembled device (implant was 
found twisted). 
 The handle on the nozzle-component was suitable for the leverage of the prototype 
through the incision site and provided an escape passage of the trapped air inside the 
breast-cavity, during implant insertion.  
During assembly and dis-assembly of the prototype device: 
 The attachment and detachment of the strap holding the components was time 
consuming and tedious.  
 The inverting-bag thickness of 0.1 mm was suitable for assessing post-insertion implant 
placement/orientation20. 
 The overall size of the prototype was suitable for the torso of the breast-model as shown 
in Figure 5.3. 
 The opaque materials used for the prototype device development were not conducive to 
accurately determining if the implant had been passed the mid-funnel and nozzle 
components.  
 Air supply through an air pipe attached to the device may not be comfortable to the 
surgeon handling the device, it may cause concerns during the surgical procedure. 
 For the purpose of the prototype device the control of the air supply was through a 
manually operated ON-OFF valve. As there was not visual confirmation that the 
implant was out of the device and inside the breast-cavity, it was not known when to 
                                                          





stop the air supply. This in turn was the main cause of inflating the inverted bag, the 
abnormal expansion of the breast-model and the rupture of the inverting-bag. 
5.3.3.5. Reliability of the Experimental Investigation 
The successful insertions into the breast-model and the breast-model for the in vitro evaluation 
of the prototype were confirmed by a plastic surgeon21. 
 
                                                          






The ‘no-touch’ insertion technique has been theoretically identified in literature as the optimal 
method in effectively reducing current capsular contracture (CC) rates via an elimination of 
insertion related bacterial contamination. The inability in achieving this ‘no-touch’ insertion 
with the traditional finger-manipulation method and, subsequent need for an insertion device 
was identified in the study problem statement (section 1.1). To be surgically adopted, this 
device is also required to promote safer and faster procedures and to be simple and easy to use. 
This is particularly for the insertion of prefilled silicone implants. The aim of this study was 
therefore, in the design and development of a silicone breast-implant insertion device that 
demonstrates (in vitro) a ‘no-touch’ technique without adversely affecting the integrity of the 
implant and the breast (section 1.2).  
The proposed device concept was designed according to constraints, requirements and criteria 
established in section 4.2, which were based on the objectives of the study (section 1.2) and 
applicable design features found in literature (section 3.3). Following the conceptual design 
(section 4.3), an implant evaluation was carried out to determine internal prototype dimensions 
(section 4.4). The design and development of the prototype (section 4.5) was further based on 
component material selections and the necessary attachments between components. Following 
the verification of the pre-selected insertion force, i.e. air pressure at 1 bar (section 5.2), silicone 
implants were inserted into a silicone cast breast-model using the prototype device (section 5.3). 
The proposed device concept was therefore, evaluated with regards to the: ‘no-touch’ insertion 
achievement, positive-displacement method and relevant ergonomics of the prototype and, the 
limitations of this in vitro study were explored.  
6.1.  Insertion Times 
The average insertion times of the three breast-model test rounds at the 1 bar (gauge) insertion 
air pressure ranged from 2.5 to 4.2 seconds (section 5.3.3.1). A statistical analysis was not 
carried out on these results, due to the small implant-sample size, which was composed of 
implants of varying: volume, shape, gel-type and surface finish. However, this variety of 
implants verified that consistent insertion was successfully achieved.  
From the data collected, it is evident that both the implant volume and gel-type influence 
insertion time. This is in keeping with the increase in insertion difficulty with larger implants 
(section 2.3.2), as well as more cohesive gel-fillers (section 3.2.2), where insertion times are an 





6.2.  Insertion Air Pressure of 1 bar (gauge) 
The maximum average insertion time of 4.2 seconds compared to the recorded plunge periods 
indicates a flaw in the plunger test used to verify the insertion force. The 1 bar insertion 
pressure (which was assessed as a safe pressure) verified that a 49 kg mass was required to 
plunge the 357.14 cm3 and 380.95 cm3 implants (Table 5.1) through a 78.5 mm diameter 
cylinder and the device outlet. The difference being in the relative short (30 seconds) and long 
plunge period (3 minutes) recorded for the 357.14 cm3 and 380.95 cm3 implants, respectively 
(section 5.2.1). While it was accurate to assume that the 1 bar pressure was sufficient for the 
380.95 cm3 implants in spite of the longer plunge period, experimentation showed that by using 
a different lubricant the insertion time was frictional-resistance-dependant and not on the type of 
implant. This suggests that the choice of device material is essential if sterile lubricants are used 
during implant/inverting-bag insertion. 
Nonetheless, the short insertion times with the breast-model test results suggest that:  
 A lower insertion pressure could be used with the insertion of implants up to 428.57 
cm3 (with a very soft gel) through a 45 mm incision and/or, 
 A larger implant volume than 428.57 cm3 (with a very soft gel) could be insertable 
through a 45 mm incision at a 1 bar insertion pressure – i.e. with the design of a 
larger implant-holder and corresponding dimensional increases on the mid-funnel-
component. 
While it appears that an insertion air pressure greater than 1 bar (gauge) is not necessary, an 
increase in this pressure may be at the risk of causing trauma to the breast-tissue. 
6.3.  Breast-Cavity Air-Removal Path  
The device was designed having a built-in retractor and a handle incorporating a perforated tube 
at the underside of the retractor and connected to a tube through the handle. This design aspect 
successfully removed the air trapped inside the breast-cavity and let it escape through the 
passage inside the handle. As literature has indicated, trapped pressurised air inside the breast, 
due to implant insertion, could cause air embolism (section 3.3.1). Therefore, through the 
experiments in this study, this aspect of the device proved to be efficient. However, the 
extensive air-supply inflated excessively the breast-cavity of the model and unknowingly at the 
time of experimentation, this observation was thought to have occurred due to the blocked air-
escape passage. It was proven later that the excessive breast inflation was due to the inverting-
bag inflation inside the breast, which also caused rupture for the bag itself. Therefore, although 





rupture indicated that a precise control of the air-supply is not only essential but detrimental to: 
(a) the health of the patient as besides air embolism, a more severe thoracic wall deformity is 
eminent, and (b) rendering the device and surgical methodology useless.  
6.4.  Achievement of the ‘No-Touch’ Insertion Technique and Safe 
Implant Handling   
Theoretically, the successful insertions into the breast-model and visible maintenance of implant 
integrity (described in section 5.3.3) indicate that the proposed device concept provides a means 
for silicone breast-implant insertions with a ‘no-touch’ technique. As a result, this verifies the 
features for: 
 Silicone breast-implant insertions through a 45 mm incision (objective no. 1). 
 An elimination of skin/implant contact (objective no. 2). 
 An elimination of an external retractor to hold the incision open throughout insertion 
(objective no. 3). 
 An elimination of direct glove/implant contact (objective no. 4). 
 An elimination of breast-tissue/implant contact (objective no. 5). 
 Safe implant handling (objective no. 6.a). 
6.4.1. Silicone Breast-Implant Insertions through a 45 mm Incision  
The successful breast-model insertions verify the use of a funnel in reducing the cross-sectional 
area of prefilled implants, as suggested by Abell et al. (2007) in section 3.3.1. This is evidently 
also a standard feature in all the existing concepts investigated in section 3.3.  
The successful insertion of the 428.57 cm3 implant (section 5.3.3), is regarded as on par with the 
400 cm3 implant insertion reported with the Keller-Funnel through a 40 mm incision (section 
3.3.2). This is considering that, while breast-model insertions were through a 45 mm incision, 
the actual proposed device outlet is equivalent to a 40 mm incision, as described in section 
4.4.2. Consequently, this potentially indicates that minimal incision lengths (section 3.2.4) may 
be achievable with the proposed device concept, in comparison to the Keller-Funnel, which has 
the advantage in reduced incision lengths (section 3.3.2).  
6.4.2. Elimination of Skin/Implant Contact  
The closed nature of the proposed concept and device placement through the incision (as 
described in device operation step no. 5 in section 4.3), protects the implant from skin contact 





infectious theory (section 3.1.4) also describes a need for protection against environmental 
bacteria such as Bacillus species. Thus, the closed nature of the proposed device further protects 
against environmental contamination throughout insertion and is therefore, superior to the open 
implant tray of the suction system by Kairinos (2011) in Figure 3.6. However, the similarity of 
the proposed device outlet to that of the suction system and placement thereof is conducive to 
an elimination of skin contact at the wound margin. This stems from the evaluated bacterial 
contamination with the use of the Keller-Funnel to have been partially due to the lack of device 
attachment at the wound (section 3.3.2). Consequently, the rigid device outlet lining the wound 
is also essential to the elimination of skin/implant contact. 
6.4.3. Elimination of an External Retractor  
The successful prototype placement, attachment and removal in the breast-model test indicate 
that the built-in retractor was effective at eliminating the need for an external retractor to the 
device. According to suggestion by Dr Kairinos, a short length of the built-in retractor was 
incorporated in the design of the prototype. In comparison to Kairinos (2011) ‘suction model’ 
the shorter retractor serves to: (a) cause no injury to the soft tissues inside the breast and (b) 
facilitates easier removal from the breast at the end of insertion. 
Conversely, the curve of the retractor was fixed according to the equivalent dome dimensions of 
the 380.95 cm3 implant (section 4.4.2). Considering the open configuration of the empty cavity 
in the breast-model (section 5.3.1), it is unclear if this curve may become problematic with the 
insertion of smaller implants in a real breast (through the 45 mm incision, medium device size). 
6.4.4. Elimination of Direct Glove/Implant Contact  
The use of the inverting-bag for elimination of direct glove/implant contact was verified by the 
successful inversion and release of the bag following insertion (section 5.3.3). This inverting-
bag feature was suggested by Zochowski (2014) however, no indication was provided as to how 
this bag is attached to the device (section 3.3.2). The proposed device concept therefore 
indicates that the operation of this bag relies on the attachment and detachment of one 
component into another with the bag trapped in between, which is achievable by a two-way 
guide and knob feature between the nozzle- and mid-funnel-components.  
It is also evident that the strength of the inverting-bag is essential for a successful insertion with 
air pressure as the insertion force (i.e. with a maximum 0.1 mm bag thickness for post-insertion 
implant orientation assessments – section 5.3.3). While it was beyond the scope of this study to 
specify final component materials, successful bag inversions confirm the use of a bag that is: 





6.4.5. Elimination of Breast-Tissue/Implant Contact  
The breast ducts have also been found to harbour and extrude skin bacteria (section 3.1.4) 
consequently, an elimination of breast-tissue/implant contact would be ideal. However, this 
relies on an elimination of breast-tissue violation with implant pocket and incision site 
selections that are deep to the breast-tissue – i.e. a submuscular/subpectoral pocket and 
inframammary incision (section 3.1.5). While the suggested pockets are also deep to large 
vessels for hematoma concerns (which is contributes to CC development), the implant pocket 
plane is largely patient dependant (section 2.3.1). Nonetheless, the inframammary incision has 
been the most effective surgical variable at reducing bacterial contamination (section 3.1.4) and 
the device was suitably designed for this site. The inframammary restriction is further validated 
by the suggested use of two incisions if a simultaneous mastopexy is required (Table 3.2). Thus, 
use at the inframammary site was achieved by the design of the eccentric shaped funnel. It is 
also assumed that the built-in retractor may assists with a potential reduction in breast-tissue 
contact, by opening the breast-cavity (in a real breast) and lifting a portion of the breast-tissue 
away from the implant (section 3.3.1).  
The extent to which a potential reduction (if not elimination) in breast-tissue contact is achieved 
is unclear from the breast-model test. However, in conjunction to an inframammary incision, the 
short insertion times (Figure 5.5) would be beneficial to a reduction in breast-tissue contact. 
This stems from the predicted reduction in bacterial contamination with quicker procedures 
(Table 3.2).    
6.4.6. Safe Implant Handling 
Despite the designed maximum insertable implant volume of 395 cm3 for the 45 mm incision, 
no visible post-insertion implant damage was observed with the breast-model test subset of up 
to 428.57 cm3 (section 5.3.3). This potentially indicates a safe implant handling with the 
eccentric funnel angle and the even distribution of insertion forces offered by pressurized air. It 
is therefore evident that the proposed method of insertion may not be at the risk of permanently 
deforming the implant shape or weakening the implant shell for insertions of up to 428.57 cm3.  
In addition to the integrity of the implant, safe implant handling also involves the orientation of 
the delivered implant. Consequently, device attachments that require the rotation of components 
also require increased skill and time for device preparation, which may still not be conducive to 
an acceptable implant delivery (section 5.3.3). This is however, related to the ergonomics of 






6.5.  The Positive-Displacement Method of Insertion  
6.5.1. The 1 bar (gauge) Insertion Air Pressure and Benefits Thereof 
Theoretically, the successful breast-model insertions (section 6.1) also imply that the positive-
displacement, 1 bar air pressure was effective at pushing the implant and inverting-bag through 
the device and into the breast-cavity (objective no. 6.b, section 1.2). This further indicates that 
the seals created by the circumferential tapers and tightly held inverting-bag at the plane of 
inversion were also effective. In addition, the rigidity of the prototype materials provides the 
required inelastic nature for this application (section 3.3.2).  
Other than a safe (implant handling) ‘no-touch’ technique, the appeal of the proposed device 
concept is also in a reduction in insertion difficulty, which is indicated by the recorded insertion 
times. The maximum insertion time in the breast-model test was recorded with the 400 cm3 
implant containing a hard gel and not the 428.57 cm3 with a soft gel (section 5.3.3.1) – thus 
indicating a gel-type influence on insertion difficulty. This potentially verifies the assumed soft 
gel-filler with the reported Keller-Funnel 500 cm3 implant insertion through a 30 mm incision 
(section 4.4.2). If this verification extends to the assumed hard gel-filler for the reported Keller-
Funnel 400 cm3 insertion through a 55 mm incision then, the proposed device concept may be 
superior to the Keller-Funnel with respect to a reduction in incision lengths. However, further 
studies would be required for this verification. Nonetheless, the maximum average insertion 
time of 4.2 seconds for the test subset is within the 3-20 seconds reported with the Keller-
Funnel (section 3.3.2) and significantly below the 5-15 minutes reported with the traditional 
finger-manipulation method (section 2.3.2). 
The short insertion times are most likely due to the more even distribution of forces offered by 
the proposed positive-displacement method. While the 1 bar insertion air pressure was subject 
to plunger test evaluations (regardless of its flaws, section 6.2), the 49 kg equivalence to this 
pressure (section 5.2.2) verifies the significant manual force predicted with the use of a plunger 
system (section 4.3) as a positive-displacement method. 
6.5.2. Insertion Resistance Reduction with the Proposed Device Concept 
The short insertion times indicate that insertion resistance is adequately overcome with the 
proposed device concept. This includes implant resistance due to friction and resistance due to 
air naturally trapped in the breast. Frictional resistance would have been overcome by the 
wound margin protection and internal lubrication of the device. While the amount of lubrication 





satisfactory insertion times were recorded. The removal of trapped air from the breast is also 
essential, for which was achieved by the retractor air-removal path. 
6.5.3. Breast Safety Concerns 
The safety of the proposed positive-displacement method is potentially threatened by the 
observed inverted bag inflation (section 6.3). While the inflation of the inverted bag indicates 
that the air-supply seals are effective, it is evident that the expandable structure (Figure C.5) 
with a liquid/air supply proposed by Ledergerber (1998) is better suited to breast safety, as a 
liquid supply can be more accurately controlled than the air supply. However, this structure 
would not achieve the required inverting-bag inversion, which is essential to direct 
glove/implant contact elimination. Alternatively, a transparent device for visible insertion 
verifications and/or an air supply safety cut-off following insertion could be paramount to breast 
safety. This material change and the cut-off mechanism are beyond the scope of this study 
(section 1.3) nonetheless, these alternatives would not adversely affect the proposed ‘no-touch’ 
technique, but are essential to the safe insertion of the implant. 
6.6.  Overall Ergonomic Evaluation of the Insertion Device 
Ergonomic evaluations that are detrimental to the proposed concept include the required 
handling of the device and the overall size relative to the torso of the breast-model (objective 
no. 7, section 1.2). Whereas, prototype related ergonomic evaluations include features that are 
not detrimental to proving the concept, i.e. the screw attachment between the device 
components, the prototype strap, material selection and the position of the air supply control 
(from Table 4.3). Consequently, these features are not herein discussed and therefore, the design 
specifications are not conclusive to these aspects of the device. 
From section 5.3.3.4, it is evident that the device handle is suitable for the leverage of the built-
in retractor, through the incision until the device outlet adequately lines the wound margin. 
Upon insertion, it is also assumed that device stability would be maintained at the handle. Since 
at the prototype design stage the air-control valve was external to the device, it caused 
undesirable effects in assessing the safe delivery of the implant. It is therefore concluded that a 
more ergonomically-correct positioning of the air valve at the top of the handle, and controlled 
by the surgeon’s thumb, would provide dexterity as well as stability of the device during 
insertion. This potentially verifies the leverage and stability functions of the device handle 





6.7.  Limitations of the Proposed Insertion Device Concept Evaluation 
Due to the nature of the experiment to proving the concept, the in vitro testing posed limitations 
to the investigation of real bacterial reduction. In doing so, the proposed device was developed 
having considered aspects discussed in previous sections of this document and successfully 
delivered the conclusive results supporting the aim of this study. 
It is anticipated that the in vivo study will explore the real-life concerns, when live breast-tissue 
during animal studies will show the efficacy of the device in time of insertion, bag inversion and 
integrity of both inverting-bag and implant. Therefore, considering the in vitro testing, the 





RECOMMENDATIONS AND FUTURE WORK  
7. RECOMMENDATIONS AND FUTURE WORK 
This study validates the proposed ‘no-touch’ breast-implant insertion device according to a 
prototype in vitro breast-model investigation. Recommendations for future device developments 
include: 
 Sterilizable material selections, consisting of transparent rigid device components with 
a low coefficient of friction (against the breast-implant) and, a 0.1 mm thick inverting-
bag durable to the 1 bar (gauge) insertion air pressure.  
 An attachment of a pressurized air-supply canister to the device (instead of the use of 
readily available air-supply in theatre). 
 A post-insertion air-supply safety cut-off mechanism. 
 Direct clip-lock device component attachments. 
The limitations of this breast-model investigation are in the inadequate implant insertion 
resistances and, inherent inability of biological related verifications of the proposed ‘no-touch’ 
technique. Consequently, the surgical validity of the proposed concept will be a study in a future 
work with in vivo investigations, for: 
 Breast safety verifications, specifically with regards to breast-cavity air-removal 
through the built-in retractor. 
 Biological ‘no-touch’ technique verifications, with regards to the amount of bacterial 
contamination following insertions using the proposed device compared to traditional as 





APPENDIX A  
APPENDIX A – Implant Pocket Planes 
Breast pocket planes include: subglandular, submuscular and subpectoral (dual plane) – as 
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APPENDIX B  
APPENDIX B – Capsular Contracture (CC) 
B.1. Capsular Contracture Occurrence Rates 
Table B.1: Capsular Contracture reported rates 
(Reference) Reported CC occurrence rates 
(Hipps et al., 1978) 4 – 74% 
(Shah et al., 1981) 40 – 50%  
(Mcgrath & Burkhardt, 1984) 0 – 74% 
(Gabriel et al., 1997) 17.5% 
(Independent Review Group, 1998) (1st & 2nd generation) 40 – 60%  
(Sarwer et al., 2000) 10 – 70% 
(Pajkos et al., 2003) Up to 74% 
(Barnsley et al., 2006) 15 – 45% 
(Araco, Caruso, Araco, Overton, & Gravante, 2009) 1.3 – 30% 
(Tamboto et al., 2010) 0.6 – 100% 
(Mofid, 2011) 10 – 30% 
(Hester et al., 2012) 0 – 74% 
(Moyer et al., 2012) 5 – 74% 
(Rieger et al., 2013) 30% 
(Bergmann et al., 2014) 4 – 60% 
 
Table B.2: Time-to-Contracture reported rates  
(Reference) 











40%- within 6 
months - - - 
(Ersek, 1991) 33.33% 50% Over 90% Remainder 
(Tweed, 2003) - 25% - - 
(Marques et 
al., 2010) - 
16% and 76%  
within 1.6 and 2 
years, respectively 
- - 
(Mofid, 2011) 58% - within 11 
months - 




Approx. 90% - - - 
(Somogyi & 
Brown, 2015)* 
1.3% - - 7.4% (after 6 years) 








Table B.3: Reported capsular contracture rates following augmentation and 
reconstructive surgeries 
(Reference) CC Occurrence Rate (%) Recon. To Augmentation Augmentation Reconstructive 
(Gabriel et al., 1997) 
6.5% - within a year 
12% - by 5 years 
Avg. patient age: 31 
21.8% - within a year 
34% - by 5 years 
Avg. patient age: 49 
3.3 times more 
2.8 times more 
(Grigg et al., 2000) - 30 – 40%  - 
(Reid et al., 2005) 4.6% 25% 5.4 times more 
(Allergan, 2007) – 5 
Year Allergan Core 
Study 
13.8% 7.6% 1.8 times less 
(Adams, 2009) 15%  
15 – 30% 2 times more 
(Allergan, 2009) – 7 
Year Core Study  
15.5% 
Avg. patient age: 34  
17.1% 
Avg. patient age: 48 
1.1 times less 
(Marques et al., 2010) 17.4% - within 3 years  Avg. patient age: 31  
47.7% - within 4 years  
Avg. patient age: 48.6  
2.7 times 
(Mofid, 2011) 30%  
73% 2.4 times 
(Brazin et al., 2014) 10%  
More than 20% 2 times 
 
Table B.4: Reported capsular contracture rates with saline and silicone implants 




24% CC rate 





contracture – 14.5 
months. 
36% CC rate 




contracture – 10.8 
months. 
No significant difference was 
determined with regards to the 
time of capsule formation.  
(Asplund, 
1984)  
20% 54% This followed reconstructive 
procedures over a 2 year 
follow-up period. However, 




7.1%- over a mean 
follow-up period of 
6.7 months 
5.6% - over a mean 
follow-up period of 
13.8 months 
No significant difference was 
determined following statistical 
analysis – result do not support 
lower CC rates with saline 
compared to silicone 
(Embrey et 
al., 1999) 






Table B.5: Reported capsular contracture rates with smooth and textured implants 
(Reference) 












2.5% Results following implantation of 330 
smooth and 122 textured implants, 
with not statistical analysis to account 






of 32.8 months 
8% 
Mean follow-up 
of 10.7 months 
Statistical analysis determined the 
reduced risk of CC with textured 
implants to be short lived – i.e. 
textured implants eventually 




23 – 40% 2 – 29% Subglandular placement in 
augmentation 
(Barnsley et 
al., 2006) - - 
A Meta-Analysis: 
CC rates were observed to be 5-times 
higher with smooth, compared to 
textured implants. However, these 
results were from short follow-up 
studies, with no indication regarding 
placement. 
(Mofid, 
2011) - - 
CC rates are 3-to-5-times higher with 
smooth implants following 
subglandular placement. 
(Hester et 
al., 2012) - - 
Did not find a decreased CC rate with 
textured implants – no indication of 
implant placement. 
 
Table B.6: Reported capsular contracture rates with subglandular and 
submuscular/subpectoral placements 
(Reference) 
CC Occurrence Rate (%) 






6.9% (subpectoral) This difference was not statistically 
significant. Furthermore, no indication 
of the incision site used was provided 
in this study. 
(Grigg et al., 
2000) 
30% 10% (submuscular) - 
(Mofid, 2011) - - 
CC rates are 8-times higher with 








Table B.7: Reported capsular contracture rates with regards to incision site 




The interval to 
development of 




The interval to 
development 




No statistical analysis 




performed at the 
inframammary site than 
the periareolar (338 vs. 
92). 
(Jacobson 
et al., 2012) 
0.5% 
The interval to 
development of 




The interval to 
development 




The interval to 
development of 









However, very small 
sample size was used 
 
B.2. Treatments for Relief of Capsular Contracture 
Non-surgical treatments have included: closed capsulotomy; the consumption or pocket 
injection of leukotriene receptor antagonists (LTRAs) – particularly Zafirlukast (ZL); and the 
application of external ultrasound on the contracted breast. And, surgical treatments have 
included: open capsulotomy; capsulectomy; and the attachment of a shaped piece of acellular 
dermal matrix (ADM) to the pectoralis muscle/s.  
High CC reoccurrence rates have been consistently reported following capsulectomies and both 
types of capsulotomies, with repeated procedures decreasing the chance of success (Grigg et al., 
2000), refer to Table B.8 for reported reoccurrence rates following open/closed capsulotomies 
and capsulectomies. Closed capsulotomies have been largely abandoned due to the required 
excessive compression on the implant – increasing the risk of: hematoma and implant shell 
rupture (Mofid, 2011). With regards to the infectious theory, this ‘breaking of the capsule’ for 
relief of the contraction does not resolve the underlying subclinical infection hence, the 
observed high reoccurrence.  This is also an applicable explanation for CC reoccurrence 
following open capsulotomies and capsulectomies (Adams, 2009). Where, cuts are made in the 
contracted capsule and the implant is reinserted with the cut capsule in an open capsulotomy – 
also for the relief of contraction. And, a capsulectomy requires the removal of the entire 
contracted capsule, followed by an implant reinsertion (Grigg et al., 2000). A further reduction 





change however, an elimination is desired (Mofid, 2011). Furthermore, replacements and 
capsulectomies required more than an hour of surgery time (Grigg et al., 2000).  
Table B.8: Reported capsular contracture reoccurrence rates following open/closed 
capsulotomy and capsulectomy 
(Reference) 
CC Reoccurrence Rates (%) 
Commentary Capsulotomy Capsulectomy Closed  Open  
(Vinnik, 1976) 25%     




(Handel et al., 
1995)   
17.4% - with implant 





33%   
 Observed within a 1 
year follow-up period. 
(Embrey et al., 
1999) 58%   
  
(Reid et al., 2005)  > 54%  21%   
(Hester et al., 2012) 
  53.4% - with implant and 
breast pocket change. 
74% reoccurrence after 
capsulectomy. 
Reoccurrences occurred 
1month to 4 years 
following capsulectomy. 
The use of LTRAs, external ultrasound and ADM in contracture treatment (and potentially 
prevention) have been largely anecdotal with short follow-up periods (Chun et al., 2010). 
Nonetheless, these methods aim to alter the capsule thickness thus, predominantly centred on 
the hypertrophic scarring theory. The application of external ultrasound from the immediate 
postoperative period has been observed to promote early stabilization of the healing process, by 
increasing cellularity, vascularity and subsequently, capsule thickness (Shah et al., 1981). 
However, with collagen fibre orientation described to be similar to those frequently reported 
around textured implants, which potentially indicates a delay in contractures (Mendes et al., 
2008). 
LTRAs (specifically ZL) have been observed to reduce capsule thickening by blockage of 
inflammatory cell mediators following the natural healing process, i.e. in the progression of  a 
chronic inflammation (Moreira et al., 2009). Whereas, ADM  has promoted the development of 
thinner capsules by providing a barrier (between the implant and surrounding tissue) that 
excludes inflammatory cells infiltrates in the natural healing process (Mofid, 2011). Conversely, 
the undesired systematic effect of ZL has resulted in liver failure etc. (Moreira et al., 2009) and 
is therefore not recommended (Adams, 2009). And, the insertion of ADM has significantly 





increase in clinical infections with ADM could be due to the increase in the pathogenic effect of 
S. aureus in the breast-tissue (Courtiss et al., 1979).  Since, the exclusion of inflammatory cells 
reduces the ability of clinical infection prevention by the natural healing process and immune 
system. Furthermore, the ADM insertion process and increase in breast-tissue manipulation 
could result in an increase in bacterial contamination, i.e. due to the more complicated 
procedure (Chun et al., 2010). ADM is also expensive (S. Becker et al., 2009) and required a 
minimum 50 mm incision length (Baxter, 2003). 
It is evident that the underlying biofilm formation and/or bacterial contamination are not treated 
with these CC treatment methods (Bartsich et al., 2011), since none of these methods have 
completely cured all contractures, nor have they proven to completely prevent contracture 





APPENDIX C  
APPENDIX C – Existing Implant Insertion Device Concepts 
C.1. BIOCELL Delivery Assistant Sleeve 
This sleeve creates a barrier between the implant and skin and, is open on both ends for the 
purpose of sleeve removal following insertion (Castello et al., 2014). Figure C.1 shows the 









C.2. Implant Pull-Devices 
C.2.1. Propulsion System (Abell et al., 2007) 










Figure C.1: Silicone implant insertion with a BIOCELL Delivery Assistant Sleeve 
(Castello et al., 2014) 
STEPS 
1. Implant is placed into the carrier-bag. 
2. The handles of the carrier-bag are 
threaded from the funnel inlet to the 
outlet, around the outside of the 
funnel, and attached at the winding 
cylinder. 
3. The funnel outlet is placed at the 
incision site. 















While an insertion failure has been predicted, it is also evident that the implant could squeeze 
out the bag in the opposite direction, potentially resulting in an implant shape deformation. This 
is due to the use of a carrier-bag open at both ends. The crank and winding cylinder attachments 
may also result in a bulky device not suitable to the surgical environment. Furthermore, the 
conical funnel shape may become problematic for insertions through an inframammary incision, 








C.3. Implant Push-Devices 
C.3.1. Disposable Implant Injector (Shiao, 1993) 











Figure C.3: Schematic representation of a rigid conical funnel and its attachment at the 









 Expanded flaps 
plunger with flat end 
implant 
implant 
Figure C.4: Disposable Implant Injector (Shiao, 1993) – everything to the right of the dashed 





While blunt, the end of the plunger applies a point load onto the implant shell which may 
adversely affect the implant integrity. Should a flat-end plunger be used, the implant may not be 
adequately pushed into the breast, since the plunger will not be able to travel through the 
decreasing cross-sectional area of the funnelled outlet. 
C.3.2. Breast Implant Introducer (Ledergerber, 1998) 
The aim of this design is primarily in an atraumatic implant delivery. This is by providing 
wound margin protection and a more even distribution of insertion forces on the implant. Of 











In this design (Figure C.5): 
 A ‘built-in’ retractor is achieved by use of a retaining ring with hinge system. The ring 
is allowed to expand once the outlet of the device has been placed through the wound. 
This is meant to stabilize the device at the incision site and provide wound margin 
protection. However, an external retractor would still be required to initially open the 
incision for device placement.  
 The rigid collar around the tube increases the thickness of the device. This may require 
a larger-than-normal incision length per implant-volume or, the forcing of a particular 









expandable structure rigid collar 
middle structure 
(optional) – a sac-
like/piston-like 





















C.3.3. The Keller-Funnel 
The Keller-Funnel is as shown in Figure C.6 and, the addition of rigid collar with attachable 





































Insertion with the Keller-Funnel has reportedly delivered a 400 cm3 silicone implant through a 
35 mm incision length at 5% of the force normally required with the finger-manipulation 
method (Keller Medical Inc., 2009). However, no indication was provided regarding the method 
used to measure these forces. 
C.3.4. Implant Insertion Device and Method of Use Thereof (Zochowski, 2014) 














A range of features are described by Zochowski (2014) in the attachment of this insertion device 
to the interior and exterior surfaces of the breast. This is so as to hold the incision open and 
stabilize the device. Alternatively, the outlet of the device can open up deep into the breast. This 
also provides wound margin protection. The implant is first placed into a bag that is either open 
on both ends or at just one end. The bag (with implant) is attached to the other components of 
the device and the user is required to push the implant into the breast-cavity by applying 
pressure on the bag (via the hands or an instrument). In the case of a bag with one open end, the 



















APPENDIX D  
APPENDIX D – Device Concepts 
D.1. Hand-Manipulation Concept 
This conceptual design was made up of two designed components, i.e. the nozzle- and mid-
funnel-component as shown in Figures D.1-D.3. The nozzle-component provides the required 
funnel shape and the mid-funnel-component is essentially described as a thick ring. For a 
positive-displacement at the aid of a hand-manipulation method, a bag-like implant-holder (to 
be attached to the mid-funnel-component) was required. This bag-like implant-holder would be 
closed on one end, due to the requirement of an inverting-bag (section 4.2). Following insertion, 
the user would be required to finger-push the bag-like implant-holder into the breast-cavity, i.e. 












An assistant may be required to maintain device stability during insertion in addition to 
preparing the device prior to insertion. Nonetheless, this design concept featured the use of 
living-hinge type pins to temporarily hold a bag-like component and a bi-unit lock mechanism 
for the device assembly. The knob on the mid-funnel-component was designed so as to assist 
with placement and rotation (along the guide path of the nozzle-component), which is necessary 
for the bi-unit lock. Since rotation of one component in another would be required for the bi-














It is evident that difficulty may be experienced in holding the living-hinge pins (down) prior to 
the placement of the mid-funnel-component into the nozzle-component, since each pin 
functions separately. Furthermore, following insertion, a portion of the inverted implant-holder 
could easily be pulled out of the breast-cavity during the required pin release, i.e. due to the 









































D.2. Plunger System 
This conceptual design was made up of five designed components: nozzle, mid-funnel, implant-
holder, plunger and plunger handle. With reference to Figure D.4, this design featured a 
horizontal device handle portion for stability as the user applies manual pressure on the plunger 
handle during insertion. To reduce insertion resistance, holes (just before the eccentric funnel 
portion) were required to allow for air release from the implant-holder as the implant is pushed 
through the device, since air would naturally be present in this space. A bi-unit lock was also 

















 Figure D.4: Plunger system (top) isometric view of assembly, (bottom) cross-


















It is evident that a steep eccentric funnel shape would be required for the face of the plunger to 
push the implant a sufficient distance through the device, since the plunger is suited to the 
constant diameter of the implant-holder. However, this was contradictory to the required 
gradual eccentric-funnel angle (section 4.2). Difficulty may also be experienced with the 
required inversion of the inverting bag, due to the flat face of the plunger. 
D.3. One-Way Guide 
This one-way guide and lock system would have been between the nozzle and mid-funnel-
components (as shown in Figure D.5). The tear shaped guide-knob (on the mid-funnel-
component) and corresponding shape in the guide-path does not allow for a detachment of these 
components following device assembly. Since, the rounded surface of the guide-knob against 
the relatively narrow neck of the guide-path was not conducive to an expansion of this neck 
should a detachment be attempted. Consequently, this type of lock design would not be 































D.4. Fabric Implant-Holder Concepts 
This concept was made up of 6 designed components (excluding the fabric): nozzle, mid-funnel, 
ring 1, ring 2, ring 3 and cap (as shown in Figure E.3). The rings and the mid-funnel-component 
were designed to trap and permanently hold the fabric with one of two methods. These included 
a one-way clip-lock or ultrasonic welding. 
D.4.1. One-Way Clip Lock 
This method for fabric entrapment was as demonstrated in Figure E.3. This type of lock relied 
on the mechanical properties of the component materials (specifically, material elasticity and 
tensile strength properties) since, rings that end up on top of other components (with the fabric 
in between) are required to briefly expand. However, based on the dimensional parameters of 


















Figure D.6: Fabric Implant holder with one way clip system. (Red circled region) 
















D.4.2. Ultrasonic Welding 
This type of fabric entrapment method required certain design consideration for the application 
of the ultrasound. For the application at hand, a near field shear joint design22 was incorporated 
into the design of the device rings instead of the one-way clips, as shown in Figure E.4. Other 
considerations and requirements for this joining method would also be required with regards to 















                                                          
22 Evaluated as an applicable design according to the Ultrasonic Plastic Joining guidelines for Branson 
equipment (Branson Ultrasonics Corporation, 2014) – which was made available from W. Lee Ultraplast 
(Pty) Ltd. 
Figure D.7: Fabric system with ultrasonic weld considerations – from Figure E.3 (light 








(i.e. near field) 





APPENDIX E  
APPENDIX E – Implant Data and Dimensional Requirements 





















Figure E.1: Diagram of the mid-funnel- and nozzle-component used to determine the device 
internal diameters according to: the device outlet, eccentric-funnel angle () equal to 38.63°, 
horizontal length from the outlet and component thicknesses (i.e. nozzle-component = 2mm 
















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































APPENDIX E  
E.3. Retractor Dimensions 
The retractor was dimensioned according to the curve of a 380.95 cm3 implant with a round 






















Figure E.2: Retractor dimensions according to a 380.95 cm3 implant (blue dotted) with base of 




APPENDIX F  
APPENDIX F – Prototype Design 
Table F.1: Features/Components used for the purpose of the prototype that were not 
essential to proving the concept 
 Features/Components not essential to 
proving the concept 
Feature/Components used for the purpose of 










holder component  
A standard M85 x 2 thread was determined as 
geometrically suitable. This allowed for a 3.25 
mm minimum thickness of the implant-holder 
(at this site). 
Nozzle-component to 
the mid-funnel- and 
implant-holder 
components 
Side handles were designed on the nozzle-
component to accommodate a strap for holding 
the components of the device together upon 
insertion. This was also so as to ensure that the 









(with solenoid valve) 
A manually operated (push-to-open) valve 
attached at the device inlet (via plastic piping). 
However, the presence of the push-button and 
wiring path was still considered in the design of 
the device handle. 
Valve connection (at 
the device inlet) 
Due to the application of air pressure, a 3/8” 
NPT with the required fittings were used, i.e. 





With regards to the bag: 
 Material 
 Dimensions  
 Thickness 
Thin film polyethylene bags (open on one end) 
were used for the inverting-bag – measured to 
be 0.05 mm in thickness. To account for an 
uneven wrapping of the inverting bag around 
the mid-funnel-component, a 0.2 mm gap was 
designed between the assembled nozzle and 
mid-funnel components. However, with no gap 































































































































































































































APPENDIX H  
APPENDIX H – Thickness and Thread Calculations 
H.1. Force Provided By 1 bar Air Pressure 
The force due to a 1 bar air supply at the cross-sectional area of the implant-holder was:  
         F = P × A       
Therefore,  




    = 483.98 N 
H.2. Component Thickness Verifications 
The tensile strength values used in the following calculations for sintered NYLON 12 (PA2200) 
and HDPE components were from Table 4.5. 
H.2.1. Circular Thin-Walled Pressure Vessels Analysis 




For sintered NYLON 12 (mid-funnel-component at Ø 78.5 mm): 
t0.0785 = 
(1 ×105)×2 ×0.0785
2 ×(45 × 106)
    
          = 1.74 × 10-4 m 
For HDPE (implant-holder at Ø 78.5 mm): 
t0.0785 = 
(1 ×105)×2 ×0.0785
2 ×(32 × 106)
         







H.2.2. Circular Thick-Walled Pressure Vessel Analysis  
From equation 4-4 considering the internal, i and outer, o stresses at the corresponding radii: 
ri = C - 
𝐵
𝑟𝑖2
      (H-1) 
ro = C - 
𝐵
𝑟𝑜2
      (H-2) 
ci = C + 
𝐵
𝑟𝑖2
      (H-3) 
co = C + 
𝐵
𝑟𝑜2
      (H-4) 
Due to the internal insertion pressure, P: 
 Internal radial stress, ri = P × SF 
 Outer radial stress, ro = 0 
 Internal circumferential stress, ci = TS (of material) 
 Outer circumferential stress, co 
For sintered NYLON 12 (mid-funnel-component at Ø 34.5 mm): 
Solving for constants C and B from equation H-1 and H-2, with ro = 20.15 mm (i.e. t = 2.9 mm) 
1 × 105 × 2 = C -  𝐵
0.017252
 
 B = C – (1 × 105 × 2 ×  0.017252) 
 B = C – 59.51 …………………………………………………………… (1) 
And, 0 = C - 𝐵
0.020152
 
 B = (4.06 × 10−4) C …………………………………………………….. (2) 
Therefore, substituting B of (2) into (1) 
 C = 59.53 
 B = 0.024 










 ci = 141.56 Pa  
H.2.3. Elliptical Thin-Walled Pressure Vessel Analysis 





For sintered NYLON 12 (nozzle-component outlet): 
tellipse = 
(1 ×105)×2 × 0.022
2 ×0.015 ×(45 × 106)
  
         = 5.93 × 10-5 m 
For HDPE ellipsoidal End-Cap (implant-holder): 
tend cap = 
(1 ×105)×2 × 0.039252
2 ×0.02 ×(32 × 106)
  
           = 2.41 × 10-4 m 
H.2.4. Elliptical Thick-Walled Pressure Vessel Analysis  
From equation 4-5 considering the internal, i and outer, o stresses at the corresponding radii: 
ri = C - 
𝐵
(𝑎𝑖 × 𝑏𝑖)
       (H-5) 
ro = C - 
𝐵
(𝑎𝑜 × 𝑏𝑜)
      (H-6) 
ci = C + 
𝐵
(𝑎𝑖 × 𝑏𝑖)
      (H-7) 
co = C + 
𝐵
(𝑎𝑜 × 𝑏𝑜)
      (H-8) 
Where, ri, ro, ci and co were as described in APPENDIX H.2.2. 
For sintered NYLON 12 (nozzle-component outlet): 






 1 × 105 × 2 = C -  𝐵
(0.02 ×0.015)
 
 B = C – (1 × 105 × 2 × 0.0003) 
 B = C – 30 ………………………………………………………………… (3) 
And, 0 = C - 𝐵
0.022 ×0.017
 
 C = (3.74 × 10−4) A ………………………………………………………. (4) 
Therefore, substituting B of (4) into (3) 
 C = 60.02 
 B = 0.022 
Substituting C & B into equation H-7 




 ci = 133.35 Pa  
H.3. Thread Verification 
For HDPE M85 × 2 thread: 




[0.085 – (0.938194 × 0.002)]2 
    = 5.427 × 10-3 m2 
From equation 4-7 (rearranged): 
     P = 𝑇𝑆 × 𝐴𝑡
𝐴 ×𝑆𝐹
 
P = (32 × 10





    = 17.94 × 106 Pa  - This is larger than the 1 bar internal pressure. With the higher tensile  
           strength of the NYLON 12 (mid-funnel-component), this thread will also  



































































































































































































































































































































































































































































































































































































































































































































APPENDIX I  
From Table I.1: 
Wp   =  mp × g      (I-1) 





















 Figure I.1: Post-plunge damage of (A) implant no. 9 (295.24 cm
3), (B) implant no. 
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